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Abstract  28 
 29 
The hypothalamic-pituitary-adrenal axis is a dynamic system regulating 30 
glucocorticoid hormone synthesis in the adrenal glands. Many key factors within the 31 
adrenal steroidogenic pathway have been identified and studied, but little is known 32 
about how these factors function collectively as a dynamic network of interacting 33 
components. To investigate this, we developed a mathematical model of the adrenal 34 
steroidogenic regulatory network that accounts for key regulatory processes 35 
occurring at different time scales. We used our model to predict the time evolution of 36 
steroidogenesis in response to physiological ACTH perturbations, ranging from basal 37 
pulses to larger stress-like stimulations (e.g. inflammatory stress). Testing these 38 
predictions experimentally in the rat, our results show that the steroidogenic 39 
regulatory network architecture is sufficient to respond to both small and large ACTH 40 
perturbations, but that coupling this regulatory network with the immune pathway is 41 
necessary to explain the dissociated dynamics between ACTH and glucocorticoids 42 
observed under conditions of inflammatory stress.  43  44 
 45 
 46 
 47 
 48 
 49 
 50 
 51 
 52 
 53 
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Significance  55 
 56 
Our ability to respond to stress depends on a remarkably dynamic process of 57 
hormone secretion. The rapid release of glucocorticoid hormones from the adrenal 58 
glands is critical to mount such an efficient response to stress, particularly during 59 
inflammation. Though many key factors involved in this process have been studied, 60 
the way in which these factors interact dynamically with one another to regulate 61 
glucocorticoid secretion has not been investigated. Here, we develop a mathematical 62 
model of the regulatory network controlling glucocorticoid synthesis and, by 63 
combining this with in vivo experiments, show how this network governs changes in 64 
adrenal responsiveness in basal unstressed physiological conditions and under 65 
exposure to inflammatory stress. 66 
\body 67 
Introduction 68 
 69 
The hypothalamic-pituitary-adrenal (HPA) axis is a stress-responsive neuroendocrine 70 
system that controls circulating levels of the vital glucocorticoid (CORT) hormones 71 
corticosterone (in rodents) and cortisol (in humans). These are steroids synthesised 72 
by the adrenal gland in response to stimulation by adrenocorticotropic hormone 73 
(ACTH), which is secreted by the anterior pituitary in response to corticotrophin-74 
releasing hormone (CRH) and arginine vasopressin released from the hypothalamic 75 
paraventricular neurons (PVN). These neurons receive circadian inputs from the 76 
suprachiasmatic nucleus (SCN), and are activated in response to stress. Via the 77 
bloodstream, CORT accesses target tissues where it mediates metabolic, cognitive, 78 
and immune responses. CORT also regulates its own production through negative 79 
feedback inhibition of ACTH and CRH secretion from the pituitary and the PVN, 80 
respectively. In order to mount an effective response to stress, CORT must be 81 
secreted rapidly by the adrenal glands. However, because of its lipophilic nature, 82 
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CORT cannot be pre-stored into vesicles, and must therefore be rapidly synthesised 83 
de novo in response to ACTH stimulation. 84 
 85 
In basal, unstressed conditions, ACTH and CORT exhibit ultradian oscillations. 86 
Although there is some evidence for pulsatility of CRH (1, 2), our recent work 87 
suggests that ACTH and CORT pulsatility is predominantly generated by a sub-88 
hypothalamic oscillator within the pituitary-adrenal system (3, 4). The amplitude of 89 
these pulses varies in a circadian manner, with larger pulses occurring at the start of 90 
the active phase (morning in humans; evening in rodents). In normal physiological 91 
conditions, CORT secretion is tightly correlated with ACTH (5). However, there are a 92 
number of conditions where a dynamic dissociation between these hormones occurs 93 
(reviewed in (6)). For example, there is evidence that pro-inflammatory cytokines 94 
released during inflammation can potentiate adrenal responsiveness to ACTH, and 95 
can activate the adrenal steroidogenic pathway directly (7). Recent examples of this 96 
are the hormonal stress responses observed during cardiac surgery in humans and 97 
in a rodent model of inflammation (8). It has been hypothesised that this dynamic 98 
dissociation is due to increased adrenal sensitivity to ACTH, presumably as a result 99 
of the effect of circulating pro-inflammatory cytokines. Thus, a better understanding 100 
of the mechanisms that regulate steroidogenesis is necessary to explain the dynamic 101 
response of CORT to both physiological and pathological ACTH perturbations. 102 
 103 
Within cells of the adrenal cortex zona fasciculata, steroidogenesis is regulated by 104 
several processes operating over a range of timescales: there are rapid non-genomic 105 
processes, as well as slower processes that depend on gene expression. Together, 106 
these form a complex pathway activated when ACTH binds the melanocortin type-2 107 
receptor (MC2R), resulting in rapid phosphorylation of proteins involved in 108 
cholesterol metabolism—the substrate for CORT synthesis. These include hormone-109 
sensitive lipase (HSL) and steroidogenic acute regulatory (StAR) proteins, which 110 
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control levels of intracellular cholesterol and its transport within the mitochondrial 111 
matrix, respectively (9, 10). In addition to these rapid, non-genomic events, ACTH 112 
simultaneously triggers a slower genomic response involving the expression of 113 
steroidogenic genes such as StAR, CYP11A, MC2R and MRAP. These genes are 114 
transcriptionally regulated by a number of nuclear receptors, whose activity and 115 
expression is also under the control of ACTH. Specifically, ACTH induces the 116 
"positive regulators" steroidogenic factor 1 (SF-1) (11) and Nur77 (NR4A1) (12), and 117 
inhibits the "negative regulator" DAX-1 (dosage sensitive sex-reversal (DSS), adrenal 118 
hypoplasia congenita (AHC) locus on the X-chromosome) (13). These interacting 119 
cascades of genomic and non-genomic events work in combination to activate and 120 
maintain optimal levels of steroidogenic proteins, ultimately leading to mitochondrial 121 
import of cholesterol and CORT synthesis. In addition, our recent mathematical 122 
modelling of the CORT response to ACTH suggests that a rapid, intra-adrenal CORT 123 
negative feedback loop constitutes an additional control mechanism of 124 
steroidogenesis (14-17). The biological processes underlying this self-inhibition are 125 
not known, but the glucocorticoid receptor (GR) is expressed in the adrenal cortex 126 
(15, 18). Furthermore, the synthetic glucocorticoid dexamethasone—a specific GR 127 
agonist—has been shown to inhibit ACTH-induced corticosterone secretion from rat 128 
adrenocortical cells (19), as well as  the transcription of steroidogenic genes through 129 
a mechanism that involves GR- and SF-1-mediated induction of DAX-1 expression 130 
(20).  131 
 132 
Though many of the components involved in the steroidogenic pathway have been 133 
identified, it remains unclear how their mutual interaction regulates CORT dynamics.  134 
In this study, we considered the core components of the steroidogenic regulatory 135 
network (SRN) and investigated how the cross-talk among these components 136 
underlies ACTH-responsive CORT dynamics. To understand the time evolution of 137 
steroidogenesis following ACTH stimulation, we developed a mathematical model of 138 
 6 
the SRN based on the complex molecular interactions within the SRN, including the 139 
intra-adrenal GR-CORT connection that feeds back on the genomic pathway. We 140 
used this model to characterise dynamic responses to a variety of perturbations, and 141 
to make predictions that we then tested experimentally. Our results show that it is the 142 
complex interactions between components of the SRN that governs dynamic 143 
steroidogenic responses in adrenocortical cells. Importantly, the SRN architecture 144 
enables cells to respond to both small and large ACTH perturbations, but is not 145 
sufficient to explain the dynamic response to inflammatory stress; in this case, we 146 
found that the CORT response can only be explained by coupling the SRN with the 147 
immune pathway. This work provides a theoretical framework to study adrenal CORT 148 
responses to a range of physiological and pathological perturbations, building upon 149 
our previous work on the role of glucocorticoid-mediated negative feedback loops 150 
regulating the ultradian dynamics of the HPA axis (3, 4). 151 
 152 
Results 153 
 154 
A short pulse of ACTH dynamically activates the SRN and CORT biosynthesis 155 
To explore systematically how dynamic responses result from complex interactions 156 
within the SRN, we developed a mathematical model of the regulatory network. To 157 
aid analysis, we restrained the complexity of the model by stripping off non-essential 158 
regulatory components from the network architecture. This was performed by 159 
including only those nodes within the SRN that have been shown to be involved in 160 
CORT-mediated feedback loops and participate in cross-talk with StAR (Fig. 1; see 161 
SI Appendix, Fig. S1 for the full SRN) (20-25). Specifically, the model consists of a 162 
set of delay differential equations (DDEs) that describe the dynamics of intra-adrenal 163 
levels of CORT (A-CORT) and phosphorylation of GR (pGR; a marker of GR 164 
activation), and the expression of DAX-1, SF-1 and StAR following “virtual” (in silico) 165 
stimulation by ACTH (SI Appendix, Fig. S2 and SI Appendix, Supp. Text). 166 
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 167 
To assist the calibration of our mathematical model, we first considered the response 168 
of the SRN to a single pulse of ACTH, similar to an endogenous ultradian pulse of 169 
ACTH (Fig. 2a). To do this, we performed an in vivo experiment in the rat to 170 
characterise the dynamic response of the adrenal SRN to an i.v. injection of ACTH. 171 
We measured both those factors in the core SRN (Fig. 1), as well as some additional 172 
factors that are also involved in steroidogenesis but were not considered in the 173 
model. The i.v. ACTH injection resulted in a rapid and transient increase in plasma 174 
ACTH (Fig. 2a), with a peak concentration comparable to the peak of endogenous 175 
ultradian ACTH pulses (26, 27). This was accompanied by a rapid and dynamic 176 
increase in CORT secretion, detectable in both adrenal tissue (A-CORT; Fig 2b) and 177 
blood plasma (P-CORT; SI Appendix, Fig S3b). To assess the dynamics of GR 178 
activation following the i.v. ACTH injection, we measured phosphorylation of GR 179 
(pGR) at Serine 211 (28). pGR demonstrated a rapid, significant increase (Fig. 2c), 180 
and its pattern of activation was similar to the observed pattern of A-CORT (Fig. 2b).  181 
 182 
ACTH also regulates steroidogenesis over a slightly slower time frame via 183 
modulation of the expression of genes involved in CORT synthesis. We therefore 184 
determined the effects of the i.v. ACTH injection on the dynamic expression of key 185 
steroidogenic genes in the adrenal SRN. Since many ACTH-regulated genes require 186 
activation of CREB in order to be transcribed, we first assessed the dynamics of 187 
CREB phosphorylation (pCREB). Consistent with previous reports (29, 30), there 188 
was a rapid and transient increase in pCREB (SI Appendix, Fig. S3d). We then 189 
investigated the dynamic transcription of steroidogenic genes by measuring their 190 
hnRNA and mRNA levels. As expected, the dynamics of pCREB was paralleled by a 191 
transient activation of StAR hnRNA, followed by a slower StAR mRNA accumulation 192 
(Fig. 2f,i). In response to the i.v. ACTH injection, there was a rapid, transient 193 
decrease in DAX-1 hnRNA, and a dynamic increase in SF-1 hnRNA (Fig. 2d,e). In 194 
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contrast, no significant changes in DAX-1, SF-1, and StARp37 protein levels were 195 
detected within two hours of ACTH administration (Fig. 2j-l). 196 
 197 
With respect to those SRN factors that were not considered in the model, we found 198 
that the i.v. ACTH injection also had a rapid effect on the activity of hormone-199 
sensitive lipase (HSL), a protein that plays a key role in the CORT SRN by regulating 200 
intracellular metabolism of cholesterol (SI Appendix, Fig. S3c). We assessed this by 201 
measuring the phosphorylation dynamics at sites known to increase HSL activity 202 
(pHSL at Serine 660 and 563) (31), and observed a dynamic activation of both 203 
pHSL-(Ser660) and pHSL-(Ser563). This suggests that a rapid, transient increase in 204 
intracellular free cholesterol precedes CORT synthesis, and supports previous 205 
findings that this is a crucial step in the steroidogenic process. Furthermore, ACTH 206 
rapidly activated hnRNA and mRNA levels of MC2R, MRAP, Nur77 and CYP11A1, 207 
but had no effect on HSL hnRNA and mRNA (SI Appendix, Fig. S3e). However, no 208 
significant changes in CYP11A1, StARp32, StARp30 or HSL protein levels were 209 
detected within two hours of ACTH administration (SI Appendix, Fig. S3f). Taken 210 
together, these results show that dynamic changes within both non-genomic and 211 
genomic processes are involved in the dynamic regulation of steroidogenesis. 212 
 213 
Next, we fitted the model to the experimental data (Fig. 2). In addition to recalibrating 214 
model parameters, we further considered a potential post-transcriptional regulatory 215 
mechanism; namely, ACTH dose-dependent control of DAX-1 mRNA stability. This 216 
proposed mechanism accounts for DAX-1 mRNA levels observed following ACTH 217 
stimuli of varying magnitude (32) (SI Appendix, Supp. Text and SI Appendix, Fig. 218 
S4). The time-evolution of the SRN was generated by driving the mathematical 219 
model with a virtual ACTH pulse given during the nadir of the circadian rhythm (SI 220 
Appendix, Fig. S2 and SI Appendix, Supp. Text). These simulations showed that the 221 
A-CORT dynamics exhibited a rising phase (<5 min), a peak ~10 min, and a falling 222 
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phase (>15 min) (Fig. 2b). Similarly, the pGR dynamics predicted by the model 223 
displayed a rising phase (<5 min), a peak ~12 min, and a falling phase (>15 min) 224 
(Fig. 2c). The model also predicted a transient induction of the SF-1 and StAR 225 
genes, as judged from their rapidly-inducible primary transcripts (heteronuclear RNA, 226 
hnRNA), mRNA, and protein dynamics (Fig. 2e,f,h,i,k,l). In contrast, the model 227 
predicted a transient inhibition of DAX-1 hnRNA, but a transient induction of its 228 
mRNA and protein levels (Fig. 2d,g,j). Taken together, these simulations closely 229 
matched the in vivo data for A-CORT and pGR dynamics, as well as gene induction 230 
(Fig. 2b-f). Whilst the changes in mRNA and protein levels measured in vivo were not 231 
statistically significant, our model still reproduced the transient dynamics of DAX-1 232 
mRNA and protein (Fig. 2g,j), and predicted a gradual increase of SF-1 and StAR 233 
mRNA and protein (Fig. 2h,i,k,l) that is consistent with the transient increase of their 234 
corresponding hnRNAs. Discrepancies between the model and experimental data 235 
may originate from unexplored post-transcriptional or post-translational regulatory 236 
mechanisms of SF-1 and StAR expression that the model does not account for.  237 
 238 
 239 
 240 
The SRN underlies the ACTH/CORT dynamic response to large perturbations 241 
comparable to those observed during inflammatory stress 242 
Our data show that an ACTH stimulus comparable to an endogenous ultradian pulse 243 
leads to dynamic changes within the SRN, ultimately driving the tightly-correlated 244 
dynamic release of CORT. However, the adrenal gland is also subjected to more 245 
forceful perturbations (e.g. those associated with severe stressors), and in some 246 
cases the tight correlation between ACTH and CORT is lost. This “dissociation” has 247 
been implicated in a change of the adrenal’s sensitivity to ACTH (reviewed in (6)), 248 
suggesting that the SRN has the ability to decode ACTH signals in a context-249 
dependent manner. Motivated by this, we used our model to investigate how the 250 
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SRN responds to a larger ACTH perturbation, comparable to that measured in 251 
response to an inflammatory stress (8), and tested our model predictions 252 
experimentally. 253 
 254 
We have previously developed an experimental methodology to apply a large ACTH 255 
stimulus to the rat adrenal glands (8). This consists of four sequential sub-cutaneous 256 
(s.c.) injections of ACTH at 35 min intervals, which results in a large surge in ACTH 257 
plasma concentrations comparable to that observed during inflammatory stress (Fig. 258 
3a). To explore how such a substantial ACTH perturbation affects the dynamics of 259 
components within the adrenal SRN, we drove our model with this same pattern of 260 
ACTH stimulation and simulated the transient dynamics of CORT and pGR, as well 261 
as DAX-1, SF-1, and StAR. Our model predicted a rapid, transient increase in A-262 
CORT consisting of a rising phase (<30 min), plateau (45 to 120 min), and falling 263 
phase (>120 min) (Fig. 3b). As expected, the pGR dynamic profile predicted by the 264 
model was consistent with that of A-CORT (Fig. 3c). In terms of gene expression, the 265 
model predicted a transient inhibition of DAX-1 gene expression, as well as a 266 
transient induction of SF-1 and StAR genes (Fig. 3d-i). Regarding protein levels, our 267 
model produced a transient activation of SF-1 and StARp37, and a gradual decline in 268 
DAX-1 (Fig. 3j-l). 269 
 270 
To test these modelling predictions, we measured the dynamic response of the rat 271 
SRN to this ACTH challenge. The increase in plasma ACTH levels was paralleled by 272 
a robust increase in both A-CORT (Fig. 3b) and P-CORT (SI Appendix, Fig. S5b). As 273 
observed in the i.v. ACTH pulse experiment, there was a dynamic increase in pGR 274 
that was consistent with the observed pattern of A-CORT (Fig. 3c). Consistent with 275 
the ACTH i.v. pulse data, there was a significant decrease in DAX-1 hnRNA and 276 
mRNA (Fig. 3d,g), and a significant increase in SF-1 and StAR hnRNA and mRNA 277 
(Fig. 3e,f,h,i). With regard to protein levels, the high dose of ACTH also induced a 278 
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significant increase in StARp30 (Fig. S5f), but not in StARp37 (Fig. 3l), StARp32 (SI 279 
Appendix, Fig. S5f), or SF-1 (Fig. 3k). There was a non-significant decrease in DAX-280 
1 protein (Fig. 3j). The dynamic effects of a high dose of ACTH on A-CORT was 281 
paralleled by an increase in both pHSL-(Ser660) and pHSL-(Ser563) (SI Appendix, 282 
Fig. S5c). Furthermore, dynamic transcription of StAR was accompanied by dynamic 283 
changes in pCREB (Fig. S5d), as well as a rapid increase in MRAP, Nur77 and 284 
CYP11A1 hnRNA and mRNA. Unexpectedly, we observed a decrease in MC2R 285 
hnRNA and mRNA, and small dynamic changes were also observed for HSL hnRNA 286 
and mRNA (SI Appendix, Fig. S5e). In contrast, there was no effect on CYP11A1 287 
and HSL protein (SI Appendix, Fig. S5f).  288 
 289 
Overall, there was a good qualitative fit between our model predictions and our 290 
experimental data for both small and large ACTH perturbations (Fig. 2 and Fig. 3, 291 
respectively). Importantly, the network architecture and parameter values in our SRN 292 
model were identical in both cases. This suggests that, for the majority of the 293 
molecular species considered in the model, no new mechanisms controlling the SRN 294 
dynamic response have to be introduced to explain the dynamic SRN responses to 295 
ACTH stimuli of varying magnitude. 296 
 297 
Dynamics of adrenal glucocorticoid synthesis and SRN activity in response to 298 
LPS 299 
Our mathematical model of the SRN suggests that the adrenal response to ACTH is 300 
primarily dependent on the specific pattern of ACTH stimulation. However, in several 301 
stress scenarios, the adrenal may not only be driven by ACTH, but may also be 302 
influenced by other factors that modulate the SRN response. For instance, activation 303 
of the immune system by administration of the bacterial endotoxin LPS is known to 304 
induce CORT secretion through a robust activation of the HPA axis, as well as 305 
through a direct effect at the level of adrenocortical steroidogenic cells (33). 306 
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Therefore, we investigated the dynamic pattern of adrenal activation in response to 307 
such a stimulus. As previously shown (8), LPS administration induced an elevated 308 
and prolonged ACTH response (Fig. 4a) that was followed by a long-lasting A-CORT 309 
(Fig. 4b) and P-CORT (SI Appendix, Fig. S6b) response. Unexpectedly, despite the 310 
high levels of A-CORT measured after the LPS injection, there was no significant 311 
effect of LPS on pGR (Fig. 4c). An elevated and long-lasting effect of LPS was 312 
observed on the genomic adrenal steroidogenic pathway, including StAR hnRNA and 313 
mRNA (Fig. 4f,i), and a multiphasic effect on SF-1 hnRNA (Fig. 4e) with a small non-314 
significant increase in SF-1 mRNA (Fig. 4h). In contrast to the decrease in DAX-1 315 
observed in the high ACTH dose experiment, we observed a biphasic dynamic effect 316 
on DAX-1 hnRNA and mRNA (Fig. 4d,g). We also measured the effects of LPS on 317 
protein levels and found that it increased the levels of StARp37 (Fig. 4l) and 318 
StARp32 (SI Appendix, Fig. S6f), and caused a non-significant increase in StARp30 319 
(SI Appendix, Fig. S6f). There was no effect of LPS on SF-1 protein (Fig. 4k), but we 320 
observed a biphasic effect of LPS on DAX-1 protein (Fig. 4j) that was consistent with 321 
DAX-1 hnRNA and mRNA.  322 
 323 
In parallel to the effect on CORT, there was a robust and prolonged effect on pHSL-324 
(Ser660) and pHSL-(Ser563), as well as dynamic changes in pCREB (SI Appendix, 325 
Fig. S6c,d). Consistent with the findings from the high ACTH dose experiment, LPS 326 
induced dynamic changes in MRAP, Nur77 and CYP11A1 hnRNA and mRNA, and a 327 
significant decrease in MC2R and HSL hnRNA and mRNA  (SI Appendix, Fig. S6e).  328 
Despite its effects on transcription, there was no effect of LPS on CYP11A1 and HSL 329 
protein (SI Appendix, Fig. S6f).  330 
 331 
Injection of LPS in the rat is also known to increase plasma cytokines in a time-332 
dependent manner (34). In addition, because LPS can also increase intra-adrenal 333 
expression of cytokines, we investigated the dynamics of these in LPS-treated rats. 334 
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As expected, LPS induced a rapid and transient increase in IL-1β hnRNA and 335 
mRNA, IL-6 hnRNA and mRNA, and TNF-α hnRNA and mRNA (SI Appendix, Fig. 336 
S7a-c). 337 
 338 
Whilst LPS increases both ACTH and cytokine levels, it is not clear whether these 339 
cytokines modulate the SRN response to ACTH and the mechanisms through which 340 
this may occur. To investigate this, we drove our model of the SRN with the ACTH 341 
pattern generated by the LPS injection, and compared its output with the 342 
experimental data (Fig. 4a). Our model roughly approximated the dynamics of A-343 
CORT and the DAX-1 hnRNA (Fig. 4b,d). In contrast, the expression dynamics of 344 
SF-1 and StAR showed some discrepancies in their hnRNA dynamics (Fig. 4e,f), 345 
where the model failed to reproduce the biphasic induction of these genes. Parallel to 346 
A-CORT, the model predicted induction and sustained activation of pGR. This was in 347 
stark contrast with our experimental data showing a lack of pGR activation despite 348 
high A-CORT (Fig. 4c). Taken together, these results suggest that a model of the 349 
SRN lacking cytokine regulation is not sufficient to explain its response to LPS. 350 
 351 
Dynamic effects of LPS-induced adrenal cytokine expression on the SRN 352 
The lack of GR activation in response to LPS, together with the fact that LPS has 353 
been shown to repress GR function in other tissues (reviewed in (35), points to an 354 
interaction between cytokines and the GR. Indeed, previous findings show that the 355 
LPS-induced pro-inflammatory cytokine TNF-α inhibits GR phosphorylation in Serine 356 
211 in human airway cells (36). In light of this, we extended our model to account for 357 
cross-talk between components of the SRN and the immune pathway, and used it to 358 
test whether these interactions could account for the observed response to LPS.  To 359 
do this, we constructed a map of the network architecture in order to elucidate its 360 
effects upon steroidogenesis (SI Appendix, Fig. S8 and SI Appendix, Supp. Text). As 361 
was the case for the full steroidogenic network, we simplified the map of interactions 362 
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between the immune pathway and the SRN (Fig. 5 and SI Appendix, Supp. Text). 363 
Further, our time course data on cytokine mRNA levels measured in the adrenal 364 
exhibits a timescale similar to cytokine protein dynamics in plasma following LPS 365 
stimulation (34). Thus, we accounted for the effects that cytokines TNF-α, IL-1β, and 366 
IL-6 have upon specific components of the SRN by using their mRNA time course 367 
data. In other words, in addition to the high ACTH response elicited by LPS we used 368 
the cytokines’ dynamic profiles as additional, selective input to specific targets within 369 
the SRN (SI Appendix, Fig. S9).  370 
 371 
We modified the mathematical model to account for these cytokine effects (SI 372 
Appendix, Supp. Text), and carried out computer simulations to explore the 373 
steroidogenic response to LPS. The mathematical model not only predicted the 374 
sustained induction of A-CORT (Fig. 6b), but also the inhibition of pGR that was 375 
observed following LPS injection (Fib. 6c; compare with Fig. 4c). The model also 376 
predicted the transient, multiphasic induction of SF-1 and StAR genes (Fig. 6e,f), as 377 
well as the transient inhibition of DAX-1 gene expression (Fig. 6d), and their 378 
associated mRNA and protein dynamics (Fig. 6g-l). 379 
 380 
Discussion 381 
 382 
Previous studies of adrenal steroidogenesis have focused on specific interactions 383 
between genes and proteins involved in glucocorticoid synthesis. Whilst these 384 
studies have provided important biological insight into the structure and regulation of 385 
key steroidogenic factors, the dynamics of the interactions of these factors across 386 
different time scales has not been considered. Indeed, using static data on individual 387 
interactions within the steroidogenic pathway has not been sufficient to explain how 388 
specific patterns of ACTH stimulation are translated by the adrenal into specific 389 
patterns of CORT secretion. 390 
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 391 
To understand this, we explored how some of these factors interact with one another 392 
in the context of a complex dynamic regulatory network. Because of the dynamic 393 
nature of steroidogenesis, we developed a mathematical model of the SRN that 394 
accounted for regulatory processes occurring at different time scales. Importantly, we 395 
also considered an intra-adrenal CORT-mediated feedback loop whose effects were 396 
previously described through mathematical modelling (17). We used our model to 397 
predict the time evolution of steroidogenesis following a series of physiological 398 
perturbations relevant to stress and inflammation. By testing these predictions 399 
experimentally, we show how the SRN can respond to both small and large ACTH 400 
perturbations, and how the coupling with the immune pathway may be necessary to 401 
elicit an ACTH/CORT dissociated response during inflammation. 402 
 403 
Mathematical models of CORT dynamics have been developed to study the origin of 404 
ultradian oscillations within the HPA axis (4, 17) and the inflammatory response at 405 
the adrenal level (37). However, these models do not consider the dynamic 406 
molecular interactions within adrenocortical cells that occur during steroidogenesis. 407 
In this study, we used a mathematical modelling approach that focuses on the 408 
adrenal cell’s network architecture, the interplay between fast and slow processes, 409 
and post-transcriptional and post-translational control of steroidogenic genes. 410 
Predictions from this model can only be of a qualitative nature, which reflects our 411 
limited knowledge on the regulatory processes that we modelled phenomenologically 412 
(e.g. using Michaelis-Menten and Hill type functions) and the uncertainties 413 
associated with some parameter values. Another limitation relates to the fact that our 414 
model did not consider all the components within the full SRN. This reflects the need 415 
to simplify our computational analysis by reducing the network architecture to its core 416 
components. Nonetheless, our results show that the SRN operates with the same 417 
core components, network architecture, and parameter values to respond to both 418 
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small and large ACTH perturbations; in other words, no new mechanisms need to be 419 
introduced to explain the adrenal’s response to a range of ACTH stimuli.  420 
 421 
We observed that rapid and transient CORT responses to ACTH stimulation are 422 
accompanied by dynamic changes in several components within the adrenal SRN. 423 
Previously, we have shown that ultradian secretion of corticosterone in the rat is 424 
paralleled by pulsatile transcription of steroidogenic genes including StAR, CYP11A, 425 
and MRAP, and pulsatile phosphorylation of CREB (29, 30, 38) suggesting that 426 
dynamic activation of the adrenal steroidogenic pathway is important for maintaining 427 
ultradian glucocorticoid secretion. In this study, we aimed to further elucidate how 428 
ACTH regulates adrenocortical dynamics in response to a pulse of ACTH. To our 429 
knowledge, we provide the first evidence of ultradian responsiveness at the level of 430 
non-genomic mechanisms within the adrenal steroidogenic pathway (i.e. 431 
phosphorylation of HSL) and within the transcriptional regulation of steroidogenic 432 
gene regulators (i.e. transcription of SF-1, Nur77 and DAX-1). These findings 433 
suggest that ultradian secretion of ACTH is important not only for a rapid “acute” 434 
adrenal response, but also for long-term maintenance of the steroidogenic pathway 435 
in basal conditions. Overall, our data suggest that dynamic events occurring within 436 
the adrenal SRN are important in maintaining ultradian secretion of glucocorticoids in 437 
a normal, healthy state.  438 
 439 
While there was a good fit between the model and the hormone, hnRNA and pGR 440 
data, some discrepancies were observed for mRNA and protein. The levels of mRNA 441 
and protein are typically thought to depend on the transcription of the gene, but 442 
additional regulatory factors such as RNA binding proteins and micro RNAs can 443 
affect the stability of transcripts. Because a role for ACTH-dependent regulation of 444 
mRNA stability in the adrenal cortex has been proposed (reviewed in Desroches-445 
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Castan et al. 2017), we hypothesise that mechanisms such as these could explain 446 
the discrepancies we have observed.  447 
 448 
Recent data from our group suggests that, in addition to the well-known CORT-449 
mediated negative feedback at the pituitary and brain regulating HPA axis activity, an 450 
intra-adrenal negative feedback involving activation of the GR can rapidly inhibit 451 
ACTH-induced glucocorticoid synthesis (17). Consistent with this, there is evidence 452 
that glucocorticoids can inhibit the transcription of steroidogenic genes through a 453 
mechanism that involves the synergistic association of SF-1 and GR to modulate 454 
DAX-1 expression (20). The present study provides further evidence to support this 455 
hypothesis by showing that a rapid, transient activation of adrenal GR tightly follows 456 
the dynamics of intra-adrenal corticosterone. To our knowledge, this is the first 457 
proposal of a model accounting for intra-adrenal feedback regulation of 458 
steroidogenesis. 459 
 460 
Further implications of an intra-adrenal CORT negative feedback loop relate to the 461 
role that the DAX-1, SF-1, and StAR genes play in controlling CORT synthesis. For 462 
instance, though DAX-1 expression is critical for normal HPA organ development 463 
(39-41), its role in regulating steroidogenesis in the adult is still unclear. SF-1 and GR 464 
have been shown to synergistically modulate DAX-1 expression (20), which in turn 465 
inhibits SF-1-mediated induction of StAR (42). ACTH is known to disrupt this SF-466 
1/GR synergistic effect on DAX-1 (20), and GR is activated by intra-adrenal CORT. 467 
This suggests that DAX-1 may be acting as an organising “hub” by simultaneously 468 
integrating and decoding hormone signals from both the pituitary and the adrenal to 469 
control steroidogenesis. If this is the case, it is possible that changes in the way this 470 
“hub” functions could lead to alterations in the way the adrenal SRN responds to 471 
ACTH perturbations. 472 
 473 
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We also studied the steroidogenic response to an LPS injection. In this case, not only 474 
the SRN but also the immune pathway was activated, as shown by the induction of 475 
cytokines TNF-α, IL-6, and IL-1β. The cross-talk between the steroidogenic and 476 
immune pathways has been modelled previously, though only at the system level 477 
(37). The mathematical model we present here is the first to incorporate a detailed 478 
description of the SRN and its interactions with the immune pathway. Notably, our 479 
model reproduced the LPS response until we explicitly accounted for the effects that 480 
cytokines have upon specific components within the SRN. This suggests that 481 
cytokines interact with ACTH to mediate the inflammatory response at the level of the 482 
adrenal SRN. Although it has been shown that a severe stressor can increase 483 
cytokine levels in the brain and pituitary even in the absence of inflammation 484 
(O’Connor K et al. 2003), and that ACTH can increase cytokine secretion in the 485 
adrenal gland in vitro (Judd and MacLeod, 1992; Call GB et al. 2000), we did not see 486 
such an increase in the level of adrenal cytokines following a high ACTH stimulation 487 
alone. 488 
  489 
A surprising finding of our study is the biphasic change in DAX-1 hnRNA, mRNA and 490 
protein observed in the LPS experiment. While we know that IL-6 down-regulates 491 
DAX-1 gene expression in bovine zona fasciculate cells, studies in different 492 
steroidogenic tissues have shown that TNF-α can increase the expression of DAX-1 493 
protein (Sadasivam 2015). Indeed, a rapid increase in TNF-α levels in plasma has 494 
been observed shortly after LPS stimulation in the rat (Givalois, 1994), and we have 495 
observed a rapid increase in TNF-α hnRNA and mRNA in this study. It is therefore 496 
tempting to speculate that a transient enhancement of DAX-1 in response to 497 
increased TNF-α may occur in the zona fasciculata of rats injected with LPS, prior to 498 
the decrease induced by IL-6. 499 
 500 
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The sustained CORT response to transient ACTH following an LPS injection 501 
suggests a disruption in the GR-mediated intra-adrenal feedback loop. This could be 502 
a factor underlying the dissociated dynamics between ACTH and CORT observed in 503 
stress scenarios. Uncovering the origin of this dissociated dynamics is key to 504 
understanding a number of physiological and pathological conditions where 505 
sustained high levels of CORT have been observed even after ACTH has returned to 506 
normal (8). Consistent with this, our model predicts that cytokine effects on the DAX-507 
1 regulatory “hub” of the SRN may explain the dynamic dissociation between ACTH 508 
and CORT during inflammation. 509 
 510 
With regard to other measured factors that were not included in the model, on the 511 
whole, we observed a dynamic activity that was consistent with the ACTH and/or 512 
LPS stimulation. However, we did observe some discrepancies with previous studies; 513 
for example, it has been shown that ACTH induces the expression of MC2R (Winnay 514 
and Hammer, 2006). However, in our study we found that, while a small pulse of 515 
ACTH increased MC2R hnRNA and mRNA, administration of LPS decreased MC2R 516 
hnRNA and mRNA. Similarly, while a pulse of ACTH had no effect on HSL 517 
expression, LPS decreased both HSL hnRNA and mRNA. This suggests that 518 
inflammatory stress can lead to a decrease in ACTH signalling and cholesterol 519 
availability, which may in turn lead to adrenal hypo-responsiveness in the longer-term 520 
that is often observed in chronic inflammation and sepsis (Boonen et al. 2015). 521 
 522 
In summary, we have presented a mathematical model of steroidogenesis that 523 
makes qualitative predictions in response to a range of ACTH stimuli. Further in vitro 524 
experiments are required to shed light on the specific molecular mechanisms 525 
regulating the cross-talk between steroidogenic genes, which would enable us to 526 
refine our models to make quantitative predictions. Nonetheless, we have shown that 527 
our mathematical model of the adrenal SRN delivers valuable insight about the 528 
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transient and rapid adrenal dynamics observed in response to ACTH perturbations 529 
during both basal and acute stress scenarios. In future work, the model could be 530 
further exploited to study several ACTH-independent mechanisms of adrenal 531 
sensitivity, such as splanchnic nerve-mediated effects on steroidogenesis (43), the 532 
effect of metabolic factors such as leptin and insulin (6), and the effects on SRN 533 
dynamics caused by acute and chronic exposure to synthetic glucocorticoids. 534 
 535 
Materials and Methods 536 
 537 
Animals and surgery 538 
All experiments were conducted on adult male Sprague–Dawley rats (Harlan 539 
Laboratories, Inc., Blackthorn, UK) weighting 220-250g at the time of arrival.  540 
Rats were anaesthetised using isoflurane and an indwelling catheter was inserted in 541 
the right jugular vein as previously described (44).  542 
 543 
Experiments and tissue collection 544 
All experiments started at 9 AM and were performed 5–7 days after the surgery. Rats 545 
were given: i) an intravenous injection of synthetic ACTH (10 ng per 0.1 ml; ACTH 546 
pulse experiment); ii) four sub-cutaneous injections of ACTH (2 μg/kg; high dose 547 
ACTH experiment; iii) an intravenous injection of LPS (25 μg/rat in 0.1 mL of sterile 548 
saline; LPS experiment). 549 
 550 
After decapitation, trunk blood was collected and plasma processed for ACTH and 551 
corticosterone measurement as previously described (Spiga et al., 2007). Adrenal 552 
glands were collected and the inner zones (comprising the zona fasciculata and the 553 
zona reticularis of the cortex and the adrenal medulla) were separated from the outer 554 
zone (containing the zona glomerulosa and the capsula). Individual inner zones were 555 
immediately frozen until processing for isolation of RNA for real-time quantitative 556 
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polymerase chain reaction (RTqPCR; left adrenal), and for protein extraction for 557 
Western immunoblotting and corticosterone measurement (right adrenal) as 558 
previously described (38, 45).  559 
 560 
Statistical analysis 561 
Data were analyzed using the non-parametric Kruskal-Wallis Test. Statistical 562 
significance was set at P < 0.05.  563 
 564 
Mathematical model 565 
We developed a mathematical model of the adrenal SRN that accounts for the time 566 
evolution of core components of the full network, namely: A-CORT, pGR, and genes 567 
DAX-1, SF-1, and StAR. The model postulates a network architecture based on 568 
known biological interactions, with parameter values estimated from the literature 569 
and calibrated using the ACTH i.v. pulse data. The network architecture and kinetic 570 
parameter values remained invariant for generating predictions about the high s.c. 571 
ACTH and LPS challenge experiments.  572 
 573 
Because of the involvement of a slow genomic pathway and a fast non-genomic one, 574 
we wrote the model in terms of a set of DDEs, where the delays were associated to 575 
the gene transcription and translation processes. Our set of non-linear, coupled 576 
DDEs was numerically integrated using XPPAUT (46) and PyDDE using a fixed time 577 
step of 0.001 min and a 4th order Runge-Kutta integrator with adaptive steps. The 578 
model development and complete set of model equations are detailed in the Supp. 579 
Text.  580 
 581 
More details on the materials and methods can be found in SI Appendix, Supp. Text. 582 
Access to data, associated protocols, code, and materials is available upon 583 
reasonable request. 584 
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Figure legends 
 
Figure 1. The simplified SRN represented in the mathematical model accounts 
for both genomic and non-genomic processes occurring at different time 
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scales. Also considered in the model are the A-CORT/GR-mediated intra-adrenal 
feedback loop, and post-transcriptional and post-translational processes, including 
the ACTH-mediated stabilisation of StARp37. 
 
Figure 2. The calibrated model reproduces the SRN dynamics following a short 
pulse of ACTH. Fitting the model to data successfully reproduced the rapid and 
transient synthesis of A-CORT (a) and GR activation (b). The model also made 
qualitative predictions about the induction of DAX-1, SF-1, and StAR genes (d-f) that 
closely matched the in vivo data. Similarly, the model approximated the expression of 
the gene products, as judged from the dynamics of mRNA (g-i) and protein levels (j-
l). Red dashed lines indicate the time of ACTH injection. Representative Western 
immunoblotting images for pGR, StARp37, SF-1 and DAX-1 are shown in SI 
Appendix, Fig. S3. 
 
Figure 3. The model reproduces the SRN dynamics following a high dose of 
ACTH. The model successfully reproduced the long and transient surges of A-CORT 
(a) and GR activation (b). The model also made qualitative predictions about the 
induction of DAX-1, SF-1, and StAR genes (d-f) that closely matched the in vivo 
data. Similarly, the model approximated the expression of the gene products, as 
judged from the dynamics of mRNA (g-i) and protein levels (j-l). Red dashed lines 
indicate the time of ACTH injections. Representative Western immunoblotting images 
for pGR, StARp37, SF-1 and DAX-1 are shown in Fig. SI Appendix, S5. 
 
 
Fig. 4. Before considering the cross-talk with the immune pathway, the model 
partially reproduces the dynamic effects of an LPS-induced pulse of ACTH on 
components of the SRN. While ignoring cytokine effects, the model successfully 
reproduced the long and sustained surge of A-CORT (a), but not of GR activation 
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(b). The model also made qualitative predictions about the gene expression 
dynamics that closely matched the DAX-1 in vivo data (d, g, j), but failed to 
reproduce the SF-1 (e, h, k) and StAR (f, i, l) gene expression dynamics. Red 
dashed lines indicate the time of LPS injection. Representative Western 
immunoblotting images for pGR, StARp37, SF-1 and DAX-1 are shown in SI 
Appendix, Fig. S6.  
Fig. 5. Cytokine effects upon targets within the adrenal SRN considered in the 
model. The transient cytokine pulses elicited by LPS were used as additional input 
functions to ACTH. 
 
Figure 6. The extended model reproduces the SRN dynamics following 
administration of LPS. After accounting for cytokine effects, the model successfully 
reproduced the long and sustained surge of A-CORT (a) and approximated the pGR 
dynamics (b). The model also made qualitative predictions about the transient 
induction of DAX-1, SF-1, and StAR genes (d-f) that approximated the in vivo data. 
Similarly, the model approximated the expression of the gene products, as judged 
from the dynamics of mRNA (g-i) and protein levels (j-l). Red dashed lines indicate 
the time of LPS injection. Representative Western immunoblotting images for pGR, 
StARp37, SF-1 and DAX-1 are shown in SI Appendix, Fig. S6. 
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Fig. S1.  The steroidogenic regulatory network (SRN). The synthesis of glucocorticoids in 
adrenocortical cells is governed at multiple levels by both genomic and non-genomic 
components. In addition to the high degree of cross-talk between these components, an 
intra-adrenal feedback loop mediated by A-CORT/GR may underlie adrenal responsiveness 
and maintain appropriate levels of glucocorticoids. 
 
 
 
 
 
  
 
 
 
 
 
Fig. S2. Virtual (in silico) computer simulations of ACTH endogenous oscillations and 
perturbations. (a) The model was driven by oscillating levels of ACTH that represented 
endogenous fluctuations. (b) A simple function representing a “virtual” pulse of ACTH. (c) 
The pulse was of a size comparable to the maximum endogenous levels in normal 
physiological conditions. (d) The “virtual” pulse was given near the nadir of the circadian 
ACTH rhythm, at approximately the same time corresponding to the in vivo experiments 
(between 8 and 9 AM). 
 
 
 
 
 
 
 
 
 
  
 
Fig. S3. A short pulse of ACTH dynamically activates the SRN and CORT 
biosynthesis. (a) Representative Western immunoblotting of the effect of a pulse of ACTH 
on intra-adrenal phospho-GR (quantification is shown in Fig. 2c in the main text). (b) A pulse 
of ACTH dynamically affects plasma CORT (P-CORT). (c) Representative Western 
immunoblotting and quantification of the dynamic effect of a pulse of ACTH on 
phosphorylation of HSL (pHSL-(Ser660) and pHSL-(Ser563)). (d) Representative Western 
immunoblotting and quantification of the dynamic effect of a pulse of ACTH on 
phosphorylation of CREB in Ser133. (e) A pulse of ACTH dynamically affects plasma CORT 
steroidogenic genes hnRNA and mRNA. (f) Representative Western immunoblotting and 
quantification of the dynamic effect of a pulse of ACTH on steroidogenic protein expression 
(quantification of StARp37, SF-1 and DAX-1 proteins is shown in Fig. 2 in the main text). For 
Western immunoblotting data, optical density was normalised to Vinculin; for RTqPCR, data 
were normalised to GAPDH mRNA levels; Western immunoblotting and RTqPCR data are 
expressed as fold induction of time 0 (n=4-7/time point). Details of asymptotic significances 
are reported in Table S2.  
 
 
  
 
 
 
 
 
 
Fig. S4. Modelling ACTH dose-dependent effects on DAX-1 mRNA stability. While an 
increasing function g+ is supported by previous experiments performed at high doses of 
ACTH, only a decreasing function g- fits our in vivo experiments at low doses of ACTH. We 
hypothesise a non-monotonous –decreasing, then increasing– response mechanism that 
successfully reproduces our data at both low and high doses of ACTH. 
 
 
 
 
 
 
 
 
 
 
  
 
Fig. S5. Dynamic synthesis of adrenal glucocorticoids and activity of the SRN 
following a high dose of ACTH. (a) Representative Western immunoblotting of the effect of 
a high dose of ACTH on intra-adrenal phospho-GR (quantification is shown in Fig. 3c in the 
main text). (b) A high dose of ACTH dynamically affects plasma CORT (P-CORT). (c) 
Representative Western immunoblotting and quantification of the dynamic effect of a high 
dose of ACTH on phosphorylation of HSL (pHSL-(Ser660) and pHSL-(Ser563)). (d) 
Representative Western immunoblotting and quantification of the dynamic effect of a high 
dose of ACTH on phosphorylation of CREB in Ser133.  (e) A high dose of ACTH dynamically 
affects plasma CORT steroidogenic genes hnRNA and mRNA. (f) Representative Western 
immunoblotting and quantification of the dynamic effect of a high dose of ACTH on 
steroidogenic protein expression (quantification of StARp37, SF-1 and DAX-1 proteins is 
shown in Fig. 3 in the main text). For Western immunoblotting data, optical density was 
normalised to Vinculin; for RTqPCR, data were normalised to GAPDH mRNA levels; 
Western immunoblotting and RTqPCR data are expressed as fold induction of time 0 
(n=4/time point). Details of asymptotic significances are reported in Table S2.  
 
 
  
 
Fig. S6. Dynamic synthesis of adrenal glucocorticoids and activity of the SRN 
following administration of LPS. (a) Representative Western immunoblotting of the effect 
of LPS on intra-adrenal phospho-GR (quantification is shown in Fig. 4c in the main text). (b) 
Administration of LPS dynamically affects plasma CORT (P-CORT). (c) Representative 
Western immunoblotting and quantification of the dynamic effect of LPS on phosphorylation 
of HSL (pHSL-(Ser660) and pHSL-(Ser563)). (d) Representative Western immunoblotting 
and quantification of the dynamic effect of LPS on phosphorylation of CREB in Ser133. (e) 
Administration of LPS dynamically affects plasma CORT steroidogenic genes hnRNA and 
mRNA. (f) Representative Western immunoblotting and quantification of the dynamic effect 
of LPS on steroidogenic protein expression (quantification of StARp37, SF-1 and DAX-1 
proteins is shown in Fig. 4 in the main text). For Western immunoblotting data, optical 
density was normalised to Vinculin; for RTqPCR, data were normalised to GAPDH mRNA 
levels; Western immunoblotting and RTqPCR data are expressed as fold induction of time 0 
(n=4-12/time point). Details of asymptotic significances are reported in Table S2.  
 
 
 
  
 
 
 
 
Fig. S7. Effect of LPS vs direct administration of a high dose of ACTH on intra-adrenal 
cytokines gene expression. The effect of LPS and high s.c. ACTH was evaluated by 
measuring the hnRNA and mRNA dynamics by RTqPCR (n=4-5/time point). Data are 
expressed as fold induction of time 0. LPS administration dynamically increased (a) IL-1b 
hnRNA (P<0.0001) and mRNA (P<0.0001), (b) IL-6 hnRNA (P<0.0001) and mRNA 
(P<0.0001), and (c) TNF-a hnRNA (P=0.006) and mRNA (P<0.0001). In contrast, 
administration of a high dose of ACTH significant decreased (d) IL-1b hnRNA (P=0.005) and 
mRNA (P=0.003), whereas only a small but significant increase was observed in (e) IL-6 
hnRNA (P=0.03) but not on mRNA (P=0.171), and a trend toward significant increase and a 
significant decrease was observed in (f) TNF-a hnRNA (P=0.067) and mRNA (P=0.02), 
respectively. 
 
 
 
 
 
  
 
 
 
Fig. S8. Cross-talk between the SRN and the immune pathway. During the inflammatory 
response elicited by LPS, the synthesis of glucocorticoids in adrenocortical cells is 
modulated by the immune pathway through cytokines. The SRN, in turn, also feeds back 
upon these cytokines, thus exhibiting cross-talk between both regulatory networks. 
 
 
 
 
 
 
 
 
  
 
 
 
Fig. S9. ACTH and cytokine “virtual” pulse input functions used in the computer 
simulations and their associated sensitivities. (a) Small pulse (low dose) of ACTH, (b) 
large pulse of ACTH integrated by four cumulative doses, (c) large pulse of ACTH elicited by 
LPS, (d-f) cytokine pulses elicited by LPS. 
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Supplementary Table 1. Primer Sequences. 
 
 Target Forward Primer Reverse Primer 
   
CYP11A1 hnRNA TGTGTGTGTGACCCCAGGAGAC CCCAGGTCCTGCTTGAGAGGCT 
CYP11A1 mRNA TGCGAGGGTCCTAACCCGGA ACCTTCCAGCAGGGGCACGA 
DAX-1 hnRNA TCCAGGCCATCAAGAGTTTC AAGCTCACCCACTTGACCAC 
DAX-1 mRNA TCCAGGCCATCAAGAGTTTC GTGCTCAGTGAGGATCTGC 
GAPDH mRNA CCATCACTGCCACCCAGAAGA GACACATTGGGGGTAGGAACA 
HSL hnRNA AGGTAGGAGCTGTACCCCTG CTGCAAAGACGTTGGACAGC 
HSL mRNA TATCCGCTCTCCGGTTGA CGAGCACTGGAGGAGTGTTT 
IL-1b hnRNA AGTTGTCCGTGTGTATGGGATG GCCAGGCAGAAAGGTTTTTGTT 
IL-1b mRNA ACCTATGTCTTGCCCGTGGA AGGTCGTCATCATCCCACGA 
IL-6 hnRNA CCCAGAGCACTCCACAAGG TCTTGGTCCTTAGCCACTCCT 
IL-6 mRNA AGCCACTGCCTTCCCTACTT GCCATTGCACAACTCTTTTCTCA 
MC2R hnRNA GAAGTCCGTGAGGTTGSACA TTGTGCGGAAGGATCCAGTTT 
MC2R mRNA GCTTTTGATCCCTGCTTTGAGTG CATCTGTTAAAGAAGGAAAGGCTGG 
MRAP hnRNA ACCTCATTCCTGTGGACGAG ACCCGCCATATTATCACTGC 
MRAP mRNA CCTCCCGGTGTGTGGCCTCT GGGGACTATGCCTTACCTGTGGGG 
NR4A1 hnRNA CTTGTGGGGTCCCTGCCTGC ACGTGGAGAAGGGGCGGTCT 
NR4A1 mRNA GCGGAACCGCTGCCAGTTCT GCATCTGGGGGCTGCTTGGG 
SF-1 hnRNA AGAGGGTGATGGGCTGCT ACCTCCACCAGGCACAATAG 
SF-1 mRNA CGCCAGGAGTTTGTCTGTCT ACCTCCACCAGGCACAATAG 
StAR hnRNA GCAGCAGCAACTGCAGCACTAC GTGCCCCCGGAGACTCACCT 
StAR mRNA CTGGCAGGCATGGCCACACA GGCAGCCACCCCTTGAGGTC 
TNF-a hnRNA CCGTGACTGTAATCGCCCTAC CTTTAGGAGGCTGCAGAGAGAC 
TNF-a mRNA AAATGGGCTCCCTCTATCAGTTC TCTGCTTGGTGGTTTGCTACGAC 
 
  
 
 
 
 
 
 
 
 Supplementary Table 2. Statistical information (P values). Related to Figs. 2–4, 6, and to 
Figs. S3,5,6. 
 
Component 
P value 
Fig. 2 and Fig. S3 Fig. 3 and Fig. S5 Figs. 4, 6 and Fig. S6 
    
ACTH <0.0001 0.002 <0.0001 
A-CORT <0.0001 <0.0001 <0.0001 
P-CORT <0.0001 <0.0001 <0.0001 
pHSL-(Ser660) <0.0001 0.001 <0.0001 
pHSL-(Ser563) <0.0001 0.003 <0.0001 
pCREB 0.001 0.028 <0.0001 
StAR hnRNA <0.0001 0.001 <0.0001 
StAR mRNA 0.067 <0.0001 <0.0001 
CYP11A1 hnRNA <0.0001 0.002 0.007 
CYP11A1 mRNA 0.013 0.051 <0.0001 
MRAP hnRNA <0.0001 <0.0001 <0.0001 
MRAP mRNA <0.0001 <0.0001 <0.0001 
MC2R hnRNA 0.016 0.051 0.002 
MC2R mRNA <0.0001 0.002 <0.0001 
HSL hnRNA 0.517 0.16 0.006 
HSL mRNA 0.221 0.021 <0.0001 
Nur77 hnRNA <0.0001 <0.0001 <0.0001 
Nur77 mRNA <0.0001 <0.0001 <0.0001 
SF-1 hnRNA 0.008 0.003 0.005 
SF-1 mRNA 0.361 0.002 0.091 
DAX-1 hnRNA 0.001 0.001 0.001 
DAX-1 mRNA 0.154 0.002 <0.0001 
StARp37 0.755 0.441 <0.0001 
StARp32 0.967 0.457 <0.0001 
StARp30 0.354 0.007 0.433 
CYP11A1 0.482 0.814 0.971 
HSL 0.777 0.993 0.146 
SF-1 0.385 0.492 0.76 
DAX-1 0.728 0.301 0.003 
pGR 0.032 0.003 0.528 
 
 
 
Supplementary Materials and Methods 
 
 
Animals 
All experiments were conducted on adult male Sprague–Dawley rats (Harlan Laboratories, 
Inc., Blackthorn, UK) weighting 220-250g at the time of arrival. Animals were given a 1-week 
acclimatization period prior to the start of the experiments, they were maintained under a 
14 h light, 10 h dark schedule (lights on at 0500 h), and housed four per cage with ad libitum 
access to food and water. All animal procedures were approved by the University of Bristol 
Ethical Review Group and were conducted in accordance with Home Office guidelines and 
the United Kingdom Animals (Scientific Procedures) Act, 1986. 
 
Surgery  
Rats were anaesthetised using isoflurane and an indwelling catheter was inserted in the 
right jugular vein as previously described (Spiga et al., 2007). In brief, the right jugular vein 
was exposed, and a silastic-tipped (Merck, Whitehouse, NJ) polythene cannula (Portex, 
Hythe, UK) was inserted into the vessel to allow substance infusion. Cannula was prefilled 
with pyrogen-free heparinized (10 IU/ml) isotonic saline; the free end was exteriorized 
through a scalp incision and then tunnelled through a protective spring that was anchored to 
the parietal bones using two stainless steel screws and self-curing dental acrylic. For the 
high dose ACTH experiment, in addition to the intravenous cannula, during the same 
surgery a subcutaneous cannula was implanted under the skin between the shoulder 
blades. After recovery, animals were housed in individual cages in a soundproof room. The 
end of the protective spring was attached to a mechanical swivel that rotated through 360° in 
a horizontal plane and 180° through a vertical plane, allowing the rats to maximize freedom 
of movement. The cannula was flushed daily with heparinized saline to maintain patency. 
 
Experiments and tissue collection 
All experiments started at 9 AM and were performed 5–7 days after the surgery. ACTH pulse 
experiment. To investigate the dynamic adrenal response to an ACTH pulse rats were given 
an intravenous injection of synthetic ACTH (10 ng per 0.1 ml, i.v.; Synachten, Alliance 
Pharma, Cheltenam, United Kingdom). High dose ACTH experiment. To investigate the 
effect of a high dose of ACTH, that is able to produce similar plasma ACTH levels as 
observed after LPSs treatment, rats were given four injections of ACTH (2 μg/kg, sc; 
Synachten Depot, AlliancePharma, Cheltenam, United Kingdom) at 35-minute intervals, as 
previously described in (Gibbison et al., 2015). LPS experiment. To investigate the dynamic 
adrenal response to an inflammatory stress rats were given an intravenous injection of LPS 
(Escherichia coli, clone 055:B5; 25 μg/rat in 0.1 mL of sterile saline; Sigma, Dorset, United 
Kingdom). 
 
At the end of each experiment, rats were overdosed with 0.2 mL of sodium pentobarbitone 
(Euthatal, 200 mg/mL; Merial, Harlow, United Kingdom) at specific time points shown in the 
figures. Trunk blood was collected in ice-cold tubes containing EDTA (0.5 M; pH 7.4) and 
Trasylol (Aprotinin, 500,000 KIU/mL, Roche Diagnostics). Plasma was separated by 
centrifugation and then stored at –80°C until processed for ACTH and corticosterone 
measurement. 
 
Adrenal glands were collected and the inner zones (comprising the zona fasciculata and the 
zona reticularis of the cortex and the adrenal medulla) were separated from the outer zone 
(containing the zona glomerulosa and the capsula). Individual inner zones were immediately 
frozen until processing for isolation of RNA for real-time quantitative polymerase chain 
reaction (RTqPCR; left adrenal), and for protein extraction for Western immunoblotting and 
corticosterone measurement (right adrenal) as previously described (Park et al., 2013; Spiga 
et al., 2011b).  
 
RNA isolation and RT-qPCR 
Total RNA was extracted from the inner zone of individual adrenals using TRIzol reagent 
(Invitrogen, Hopkinton, MA, USA), followed by purification using RNeasy mini kit reagents, 
and column DNase digestion (Qiagen, Valencia, CA, USA) to remove genomic DNA 
contamination. Complementary DNA was reverse transcribed from 1 μg of total RNA using 
Cloned AMV First-Strand cDNA synthesis kit (Invitrogen). Primers were designed to 
specifically detect primary transcript (hnRNA) or mRNA (Table S1). Fast SYBRGreen Master 
(Applied Biosystems, Foster City, CA, USA) was used for the amplification mixture with each 
primer at a final concentration of 200 nm and 2 μl of cDNA for a total reaction volume of 
25 μl. PCR reactions were performed on a spectrofluorometric thermal cycler. The 
expression of each target gene was normalized to glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) mRNA as determined in a separate real-time PCR 
reaction. The absence of RNA detection when the reverse transcription step was omitted 
indicated the lack of genomic DNA contamination in the RNA samples. 
 
Western immunoblotting  
Whole cell lysate from the inner zone of individual adrenals were prepared using RIPA buffer 
(Sigma) supplemented with 0.2 mM Na orthovanadate, 2 mM NaF, and Complete Protease 
Inhibitor (Roche Diagnostics Ltd., Burgess Hill, UK). Protein concentration was quantified 
by spectrophotometry using the Pierce BCA protein assays, (Thermo Fisher Scientific Inc. 
Rockford, IL, USA). Aliquots of each sample (10–15 μg of protein) were loaded and 
separated in a 10% or 4–15% Tris–Glycine gel (BioRad, Hercules, CA, USA), transferred to 
a PVD membrane (GE Amersham Biosciences, Piscataway, NJ, USA), blocked with 5% 
non-fat milk or 1% bovine serum albumin (BSA, sigma) in 1 × Tris-buffered saline plus 
0.05% Tween 20 (TBST) and incubated overnight with Aliquots of each sample (10–15 μg of 
protein) were loaded and separated in a 10% or 4–15% Tris–Glycine gel (BioRad, Hercules, 
CA, USA), transferred to a PVD membrane (GE Amersham Biosciences, Piscataway, NJ, 
USA), blocked with 5% non-fat milk or 1% bovine serum albumin (BSA, sigma) in 1 × Tris-
buffered saline plus 0.05% Tween 20 (TBST) and incubated overnight with antibodies to 
StAR, DAX-1, CYP11A1, HSL, GR (Santa Cruz Biotechnologies, Inc., Dallas, TX, US), SF-1 
(Upstate Biotechnlogies Inc., Lake Placid, NY, US); CREB, phospho-CREB(Ser133), 
phospho-HSL(Ser660), phospho-HSL(Ser563); phospho-GR(Ser211) (Cell Signalling 
Technology, Danvers, MA, US). 
 
After washing with TBST, the membranes were incubated with a horseradish peroxidase-
conjugated donkey anti-rabbit IgG or donkey anti-goat IgG (Santa Cruz Biotechnologies). 
Immunoreactive bands were visualized using ECL Plus TM reagents (GE Amersham 
Biosciences) followed by exposure to BioMax MR film (Eastman Kodak; Rochester, NY, 
USA). After film exposure, blots were stripped and assayed for anti-goat vinculin (Santa 
Cruz Biotechnology). The intensity of the protein targets bands integrated with the area was 
quantified using a computer image analysis system, Image J (developed at the National 
Institutes of Health and freely available at: http://rsb.info.nih.gov). Data points for each gene 
were then normalized relative to the vinculin band in the respective sample. 
 
Hormone measurement  
Adrenal CORT was measured in adrenal whole cell extract prepared for Western blotting 
and CORT levels were normalized to the total protein content. Total plasma and adrenal 
CORT was measured by radioimmunoassay (RIA) using a citrate buffer (pH 3.0) to denature 
the binding globulin as previously described (Spiga et al., 2007). Antiserum was kindly 
supplied by Professor Gabor Makara (Institute of Experimental Medicine, Budapest, 
Hungary) and [125I] CORT was purchased from Izotop (Budapest, Hungary). ACTH in 
plasma was measured by RIA using a commercially available assay (MP Biomedicals, Santa 
Ana, California, USA) in accordance with the manufacturer’s instructions. 
 
 
Statistics  
Sample sizes in each experiment were determined on the basis of pilot studies and 
previous experience with similar experimental design. Animals were allocated to each 
experimental group (time point after treatment) by simple randomization. Experimenters 
were blinded to the experimental group at the time of hormones, RNA and protein 
measurements.  
 
Data are represented as the mean ± SEM, hnRNA, mRNA and protein data are expressed 
as fold induction of basal (time 0). No animals or samples were excluded from statistical 
analysis.  To check data for normality and equality of variance, we used Shapiro-Wilk and 
Leven tests, respectively. The overall effect of treatments was analysed using the 
Independent-Samples Kruskal-Wallis Test. Asymptotic significances for each experiment are 
shown in Table S2. Statistical significance was set at P < 0.05.  
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1 Model Development
The adrenal SRN controlling the CORT biosynthetic pathway is very complex (Fig. S1). In order
to develop a useful yet, manageable mathematical model, we simplified the network by reducing
the number of components to a minimum (Fig. 1). Our model predictions support these gene
components as the core regulatory clockwork of the SRN. A list of source references to the connections
between nodes in both the full and reduced network is shown in Table A.
The mathematical model is representative of a single adrenocortical cell stimulated by an ACTH
input. Specifically, ACTH stimulates adrenocortical cells for controlling the biosynthesis of CORT,
which, respectively, represent the ‘input’ and ‘output’ of the SRN. Since our model is decoupled
from other components of the HPA axis, we reproduced endogenous ACTH levels originated from
the brain by using an ultradian oscillatory input (T = 75 min) with circadian modulated amplitude.
Thus, in basal, non-stressed conditions, the model dynamics is not static but exhibits an ultradian
and circadian rhythmicity driven by the ACTH input. Some model assumptions and biological
considerations are the following:
i) The model doesn’t focus on the specifics of the CORT biosynthetic pathway within the mi-
tochondria or its release into the bloodstream. Instead, we consider A-CORT as a better
readout of the network since its increase occurs earlier than P-CORT, thus reflecting the very
first product of CORT biosynthesis.
ii) The network architecture emphasises the crosstalk between StAR, DAX-1 and SF-1 genes. For
each of these genes, their hnRNA, mRNA and protein species are modelled explicitly. Though
MC2R, MRAP, Nur77 and HSL genes are included in the full network map (Fig. S1), the
network architecture suggests they’re not directly involved in feedback regulation within the
genomic pathway.
iii) Likewise, even though the dynamics of the di↵erent phosphorylation states of the HSL protein
(pHSL-S565, pHSL-S563 and pHSL-S660) is important to understand cholesterol synthesis,
it is StARp37 the one controlling the mitochondrial import of cholesterol, which is the rate-
limiting step for ACORT biosynthesis. Accordingly, we didn’t include the pHSL dynamics in
the present model.
iv) To decouple the intra-adrenal system from the whole HPA axis, we assumed ACTH as an
externally controlled input that targets specific components within the adrenal SRN. This
took the form of either an endogenous ultradian input with circadian amplitude, a single pulse
perturbation, or a combination of both.
Furthermore, we simplified the model by reducing the number of model equations. For instance,
cAMP, PKA and pCREB intermediary species in the signalling cascade ending in promoter regula-
tion are not modelled explicitly. Though pCREB is known to regulate transcription of StAR [Manna
et al., 2009; Sugawara et al., 1997a,b; Zhao et al., 2005] as well as of other steroidogenic genes, the
components of the cascade are known to be downstream of the ACTH pathway, which is already
considered in the model.
To reproduce experimental conditions, we administered “virtual” ACTH pulses near the circadian
nadir of the endogenous ACTH oscillations. Specifically, we simulated 7 pulses, one every 10 min,
distributed between 8 AM and 9 AM of the day. The dynamics during the 120 min following the
stimuli was recorded and averaged for the ACTH i.v. pulse experiments, and during 240 min for the
high s.c. ACTH and LPS challenge experiments.
2
1.1 DAX-1 Gene Expression
The dynamics of gene activation, represented by the newly synthesised, non-edited hnRNA dax11,
can be represented by the following equation:
˙dax1 =  dax1 + kdax1fdax1(SF1, pGR)g
 
dax1(ACTH)   dax1dax1 (1)
where  dax1 is the basal transcription rate, kdax1 is the maximum transcription rate,  dax1 is the
dax1 hnRNA degradation rate, and fdax1 is a function accounting for dax1 transcription initiation
by the synergistic action of SF1 and pGR, which is modulated by ACTH. Since the specific molecular
mechanisms governing the Dax12 promoter activation are still poorly understood, we take an heuris-
tic approach and propose a phenomenological function that captures the e↵ects observed in the study
by [Gummow et al., 2006], in which SF1 and GR were cotransfected with a Dax1-Luc reporter into
JEG3 cells and stimulated with varying doses of dexamethasone (thus mimicking steroid activation
of the GR). Subsequently, a similar experiment was performed in Y1 cells which were concomitantly
stimulated with ACTH to assess the level of induction when SF1 and GR were present separately
or simultanouesly.
CORT-activated GR, which we measured via its phosphorylated form pGR, is known to synergise
with SF1 to enhance Dax1 gene expression (up to 30-fold activation in a dose-dependent dexam-
ethasone stimulation experiment). In addition, SF1 is known to also activate the promoter in a
pGR-independent way (11-fold activation). Moreover, Glucocorticoid Responsive Elements (GREs)
have been identified in the Dax1 promoter and they are dose-responsive to dexamethasone stimula-
tion in the absence of SF1 [Gummow et al., 2006]. However, we will not consider SF1-independent
e↵ects on fdax1 as the elicited fold activation is not only very close to baseline but also small when
compared against SF1-pGR synergistic activation and SF1-dependent induction. Further experi-
ments performed by [Gummow et al., 2006] suggest that SF1 and pGR form a molecular complex at
the Dax1 promoter which enhances its expression upon steroid stimulation. Considering this and the
role that SF1 has in regulating the expression of the StAR gene after binding to the DAX1 protein
(thus forming another molecular complex) [Sugawara et al., 1997a,b; Fan et al., 2004; Gummow
et al., 2006; Manna et al., 2009], we propose that fdax1 takes the form:
fdax1(SF1, pGR) =
SF1
KSF1
+ SF1·pGRKSF1·KG
1 + SF1KSF1 +
SF1·pGR
KSF1·KG
(2)
In Eq. 2, it can be seen that SF1 is necessary for activating the Dax1 promoter, either inde-
pendently (i.e. in its free form) or forming a complex with pGR. Thus, pGR can be viewed as
an enhancer which acts upon Dax1 promoter through the SF1-pGR complex. The non-linearity
observed in Eq. 2 is expected from the pGR-independent SF1 binding to any of its three binding
sites within the Dax1 promoter and from the synergy between the central SF1 binding site and
the proximal GRE binding site that enhances expression [Gummow et al., 2006]. As the specific
mechanisms of regulation are unknown, we chose the simplest empirical representation of the Dax1
promoter regulation by SF1 and pGR transcription factors.
Furthermore, [Gummow et al., 2006] also show that both the SF1 and SF1-pGR synergistic acti-
vation of the Dax1 promoter are decreased upon ACTH stimulation. We modelled this by multiplying
the second term in Eq. 1 by a decreasing function g dax1(ACTH). As the specific mechanisms and
molecular intermediaries of ACTH-dependent modulation are unknown, it is convenient to choose
a non-linear Hill type function (see Eq. 3). The K’s in Eqs. 1 and 2 account for half-maximum
constants which were determined by fitting the model to data.
g dax1(ACTH) =
KACTHdax1
4
KACTHdax1
4
+ACTH4
(3)
1The hyphen in dax-1, Dax-1, DAX-1, sf-1, Sf-1, SF-1, and A-CORT labels was dropped to avoid confusion with
a minus sign.
2In what follows, the non-italicised nomenclature will be used for gene names unless otherwise specified, whereas
the italicised will be reserved for state variables used in the mathematical model (e.g. dax1, Dax1, and DAX1 refer,
respectively, to hnRNA, mRNA, and protein concentrations).
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The mature transcript dynamics is given by
˙Dax1 = kDax1dax1⌧Dax1    Dax1Dax1 · g⌥Dax1(ACTH) (4)
where kDax1 stands for the mRNA maturation rate and  Dax1 is the mRNA degradation rate. RT-
PCR experiments aimed at detecting hnRNA can’t distinguish the transcriptional stage at which the
RNA is within the nucleus. However, we know that edition processes such as splicing have finished
once mature mRNAs are detected. Hence, we assumed Eq. 4 is delayed by ⌧Dax1, which accounts for
the elapsed time since transcription initiation up to the emergence of a hnRNA plus the maturation
time after completion of transcription (splicing, capping, polyadenylation and mRNA nuclear export
processes).
In addition, high doses of ACTH are known to destabilise Dax1 transcripts [Ragazzon et al.,
2006], which in a first instance was modelled by multiplying the turnover term in Eq. 4 by a positively
increasing function of ACTH (g+Dax1(ACTH)). However, when re-calibrating the model by fitting
it to our ACTH i.v. pulse experiments, we observed a mismatch between its predictions and our
DAX1 mRNA and protein data. We realised that our assumption of a monotonously-increasing
function was based on experimental results by [Ragazzon et al., 2006] that were performed using
very high levels of ACTH. Thus, to fit our model to data from low ACTH i.v. pulse experiments,
but keeping consistency with previous observations by [Ragazzon et al., 2006] at high ACTH levels,
we hypothesised an ACTH dose-dependent control mechanism of Dax1 mRNA stability that was
modelled assuming its turnover rate is modulated by the function g⌥Dax1(ACTH). Though it’s
not clear how ACTH actually promotes or inhibits degradation of Dax1, we propose that a non-
monotonous regulatory function would provide the best fit of the model to our experimental data
in both the low and high ACTH stimuli experiments. We model this through a decreasing-then-
increasing function containing two half-maximum constants: KACTH loDax1 for inhibition at low doses
of ACTH, and KACTH hiDax1 for activation at high doses of ACTH (Fig. S4). This function takes the
form:
g⌥Dax1(ACTH) =
KACTH loDax1
KACTH loDax1 +ACTH
+
ACTH
KACTH hiDax1 +ACTH
(5)
Finally, the DAX1 protein dynamics is governed by:
˙DAX1 = kDAX1Dax1⌧DAX1    DAX1DAX1 (6)
where kDAX1 stands for the protein translation rate, ⌧DAX1 is the delay associated to translation,
and  DAX1 is the protein degradation rate.
1.2 SF-1 Gene Expression
The dynamics of gene activation, represented by the newly synthesised, non-edited sf1 hnRNA, can
be represented by the following equation:
˙sf1 =  sf1 + ksf1g
+
sf1(ACTH)   sf1sf1 (7)
where  sf1 is the basal transcription rate, ksf1 is the maximum transcription initiation rate, and
 sf1 is the sf1 degradation rate. To the best of our knowledge, the SF1 gene is not subject to
transcriptional regulation by any of the proteins considered in the model. Thus, conversely to Eq. 1,
here we have no function accounting for sf1 transcription modulation by any transcription factors
other than the e↵ects induced by ACTH. This is modelled by a function g+sf1(ACTH), which takes
the form:
g+sf1(ACTH) =
ACTH4
KACTHsf1
4
+ACTH4
(8)
Though in our model we consider that SF1 gene expression is regulated by ACTH alone [Ragazzon
et al., 2006], regulation by other transcription factors within the steroidogenic pathway cannot be
ruled out. This poses interesting questions about the role of this gene in controlling the adrenal
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response. Moreover, evidence suggests that its mRNA and protein levels remain constant after
variations in cAMP concentration, which is a known mediator of the ACTH pathway [Fan et al.,
2004].
The mature transcript dynamics is given by:
˙Sf1 = kSf1sf1⌧Sf1    Sf1gSf1(Sf1) (9)
where kSf1 stands for the mRNA maturation rate and  Sf1 is the mRNA degradation rate. By
similar arguments as in Eq. 4, we assumed Eq. 9 is delayed by ⌧Sf1. Importantly, we found out that
the best fit of the model to our data was achieved when assuming a Michaelis-Menten degradation
of Sf1 mRNA. Thus, the function hSf1(Sf1) takes the form:
hSf1(Sf1) =
Sf1
KSf1 + Sf1
(10)
Finally, the SF1 protein dynamics is governed by:
˙SF1 = kSF1Sf1⌧SF1    SF1SF1 · g SF1(ACTH) (11)
where kSF1 stands for the protein translation rate, ⌧SF1 is the delay associated to translation, and
 SF1 is the protein degradation rate. Since ACTH is suspected to stabilise SF1, probably through
phosphorylation or ubiquitination of the proteasome [Æsøy et al., 2002], we assume its turnover rate
is modulated by a function g SF1(ACTH), which takes the form:
g SF1(ACTH) =
KACTHSF1
KACTHSF1 +ACTH
(12)
1.3 StAR Gene Expression
The dynamics of StAR gene activation, represented by the newly synthesised, non-edited stAR
hnRNA, can be represented by the equation:
˙stAR =  stAR + kstARfstAR(SF1, DAX1)g
+
stAR(ACTH)   stARstAR (13)
where  stAR is the basal transcription rate, kstAR is the maximum transcription initiation rate,
 stAR is the stAR degradation rate, and fstAR is a function accounting for stAR transcription ini-
tiation controlled positively by SF1 and negatively by DAX1. This DAX1-mediated steroidogenic
inhibition follows from the finding that DAX1 inhibits SF1 transactivation upon binding it [Babu
et al., 2002; Fan et al., 2004], thus preventing StAR gene activation. In addition, ACTH is known to
control the StAR gene activation directly through pCREB [Sugawara et al., 1997a,b; Manna et al.,
2009]. However, since we’re not modelling pCREB explicitly, we employ the function g+stAR(ACTH)
to model the StAR gene activation by ACTH. This function takes the form:
g+stAR(ACTH) =
ACTH4
KACTHstAR
4
+ACTH4
(14)
In summary, an SF1 dependent activation mechanism, similar to the one modelled in Eq. 2, has
been shown to be responsible for StAR gene activation [Sugawara et al., 1997b; Manna et al., 2003;
Fan et al., 2004; Xu et al., 2009]. This follows from cotransfection experiments carried out by [Fan
et al., 2004] to explore the e↵ects of SF1 (a.k.a. Ad4BP) and DAX1 concomitantly with Forskolin
stimulation of the PKA pathway.
These considerations were taken into account to assume that fstAR takes the form:
fstAR(SF1, DAX1) =
SF1
KSF1
1 + SF1KSF1 +
DAX1
KD
(15)
In Eq. 13, it can be seen that both ACTH and SF1 are necessary for activating stAR, whereas
DAX1 modulates the promoter activity by binding to SF1 at the promoter site (the gene is inactive
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if either ACTH or SF1 are absent, but not if DAX1 is). Importantly, this empirical approach
facilitates modifying Eq. 15 if we wish to account for DAX1 dosage dependent e↵ects observed in
diseased states [Xu et al., 2009; Sadasivam et al., 2015]. Just as in Eq. 2, the K’s in Eq. 15 account
for half-maximum constants (often interpreted as sensitivities) and were determined by fitting the
model to data.
The mature transcript dynamics is given by:
˙StAR = kStARstAR⌧StAR    StARhStAR(StAR) (16)
where kStAR stands for the mRNA maturation rate and  StAR is the mRNA degradation rate. By
similar arguments as in Eq. 4, we assumed Eq. 16 is delayed by ⌧StAR. Importantly, we found out
that the best fit of the model to data was achieved when assuming a Michaelis-Menten degradation
of StAR mRNA. Thus, the function hStAR(StAR) takes the form:
hStAR(StAR) =
StAR
KStAR + StAR
(17)
Finally, for the StAR protein dynamics we will account for the 37 kDa precursor, as it has been
shown to be the one responsible for cholesterol import before being itself cleaved and imported to
the mitochondria [Arakane et al., 1998; Bose et al., 2002; Manna et al., 2009]. It’s dynamics is given
by:
˙StARp37 = kStARp37StAR⌧StARp37   µStARp37StARp37g StARp37(ACTH) (18)
where kStARp37 stands for the protein translation rate, ⌧StARp37 is the delay associated to translation,
and µStARp37 =  StARp37 + ✏StARp37 is the StARp37 turnover rate. This value accounts for the
proteasome-mediated degradation rate of the active precursor StARp37,  StARp37, and the import
rate of the StARp37 cleaved byproducts into mitochondria, ✏StARp37 [Arakane et al., 1997; Bose
et al., 2002; Manna et al., 2009]. As it has been show that StARp37 activity is proportional to
its residence time in the cytosol [Bose et al., 2002; Granot et al., 2003], and that PKA-mediated
phosphorylation stabilises the precursor [Clark and Hudson, 2015], we have included the function
g StARp37(ACTH) in the turnover term in Eq. 18, which takes the form:
g StARp37(ACTH) =
KACTHStARp37
4
KACTHStARp37
4
+ACTH4
(19)
1.4 A-CORT Dynamics
As mentioned before, the CORT biosynthetic pathway within the mitochondria won’t be modelled
explicitly at this stage. Instead, we assume that ACORT dynamics is governed by:
˙ACORT = kACORT fACORT (StARp37)  µACORTACORT (20)
where kACORT is the maximum synthesis rate of ACORT, and the turnover term µACORT =
 ACORT + ✏ACORT accounts for the ACORT degradation rate  ACORT and the export rate from
the adrenal cell into the bloodstream ✏ACORT . The function fACORT expresses the dependence of
ACORT synthesis on the precursor StARp37 and takes the form:
fACORT (StARp37) =
StARp37
KStARp37 + StARp37
(21)
where the big K has the same meaning as in previous functions and was determined by fitting
the model to data. As mentioned before, StARp37 controls the import of cholesterol into the
mitochondria [Bose et al., 2002], which is the rate limiting step for corticosteroid biosynthesis. We
assumed this process can be represented as a Michaelis-Menten reaction (see Eq. 21) [Arakane et al.,
1997; Manna et al., 2009; Spiga et al., 2014]. Importantly, although StARp37 is downstream of
ACTH (through regulation of the StAR gene), ACORT is known to respond to ACTH stimulation
on a much shorter timescale than the time needed for ACTH to exert its e↵ects on StARp37 through
the cAMP/PKA/pCREB pathway. This likely happens due to PKA mediated StARp37 stabilisation
in the cytosol upon ACTH stimulation [Arakane et al., 1997; Manna et al., 2009], a process that is
already accounted for in the turnover term in Eq. 18.
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1.5 pGR Dynamics
Lastly, instead of modelling the concentration of the glucocorticoid receptor, we model the measured
levels of its phosphorylated form pGR, a marker of its activity. We propose the dynamics of the
pGR is governed by:
˙pGR = kGRfpGR(ACORT )   pGRpGR (22)
where kpGR stands for the pGR activation rate by ACORT and  pGR is it’s deactivation rate. The
function fpGR takes the form:
fpGR(ACORT ) =
ACORT
KACORT +ACORT
(23)
where KACORT stands for the half-maximum constant of pGR activation by ACORT.
1.6 Model Equations for the SRN
The complete set of model equations is shown below:
˙dax1 =  dax1 + kdax1fdax1(SF1, pGR)g
 
dax1(ACTH)   dax1dax1,
˙Dax1 = kDax1dax1⌧Dax1    Dax1Dax1g⌥Dax1(ACTH),
˙DAX1 = kDAX1Dax1⌧DAX1    DAX1DAX1,
˙sf1 =  sf1 + ksf1g
+
sf1(ACTH)   sf1sf1,
˙Sf1 = kSf1sf1⌧Sf1    Sf1hSf1(Sf1),
˙SF1 = kSF1Sf1⌧SF1    SF1SF1g SF1(ACTH),
˙stAR =  stAR + kstARfstAR(SF1, DAX1)g
+
stAR(ACTH)   stARstAR,
˙StAR = kStARstAR⌧StAR    StARhStAR(StAR),
˙StARp37 = kStARp37StAR⌧StARp37   µStARp37StARp37g StARp37(ACTH),
˙ACORT = kACORT fACORT (StARp37)  µACORTACORT,
˙pGR = kGRfpGR(ACORT )   pGRpGR.
where:
g dax1(ACTH) =
KACTHdax1
4
KACTHdax1
4
+ACTH4
,
g⌥Dax1(ACTH) =
KACTH loDax1
KACTH loDax1 +ACTH
+
ACTH
KACTH hiDax1 +ACTH
,
g+sf1(ACTH) =
ACTH4
KACTHsf1
4
+ACTH4
, g SF1(ACTH) =
KACTHSF1
KACTHSF1 +ACTH
,
g+stAR(ACTH) =
ACTH4
KACTHstAR
4
+ACTH4
, g StARp37(ACTH) =
KACTHStARp37
4
KACTHStARp37
4
+ACTH4
,
hSf1(Sf1) =
Sf1
KSf1 + Sf1
, hStAR(StAR) =
StAR
KStAR + StAR
,
fACORT (StARp37) =
StARp37
KStARp37 + StARp37
, fpGR(ACORT ) =
ACORT
KACORT +ACORT
,
fdax1(SF1, pGR) =
SF1
KSF1
+ SF1·pGRKSF1·KG
1 + SF1KSF1 +
SF1·pGR
KSF1·KG
, fstAR(SF1, DAX1) =
SF1
KSF1
1 + SF1KSF1 +
DAX1
KD
.
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Node Target Sign E↵ect References
ACTH dax1 – Inhibits SF1-dependent activation [Gummow et al., 2006]
Dax1 ⌥ Modulates mRNA stability [Ragazzon et al., 2006]
sf1 + Promoter activation [Ragazzon et al., 2006]
SF1 – Protein stabilisation [Æsøy et al., 2002]
stAR + pCREB-mediated promoter activation [Sugawara et al., 1997a]
[Sugawara et al., 1997b]
[Zhao et al., 2005]
[Manna et al., 2009]
StARp37 + PKA-mediated protein stabilisation [Arakane et al., 1997]
[Manna et al., 2009]
HSL + PKA-mediated activation (S563 and S660) [Manna et al., 2013]
+ AMPK-mediated activation (S565) [Watt et al., 2006]
mc2r + Promoter activation [Winnay and Hammer, 2006]
mrap + Promoter activation [Gorrigan et al., 2011]
ACORT pGR + Activation through phosphorylation - - -
pGR dax1 + SF1-dependent enhancement of Dax1 [Gummow et al., 2006]
DAX1 stAR +/– Inhibits SF1-dependent activation [Sugawara et al., 1997a]
[Sugawara et al., 1997b]
[Fan et al., 2004]
Activation at high doses [Xu et al., 2009]
mc2r + Promoter activation [Xu et al., 2009]
nur77 – Promoter inhibition [Song et al., 2004]
NUR77 – Protein inhibition [Song et al., 2004]
SF1 dax1 + Promoter activation [Gummow et al., 2006]
stAR/mc2r + Promoter activation [Babu et al., 2002]
[Gummow et al., 2006]
[Winnay and Hammer, 2006]
StARp37 StARp30/Chol + Cholesterol import to mitochondria [Arakane et al., 1997]
[Manna et al., 2009]
HSL-S660/Chol + Cholesterol biosynthesis [Shen et al., 2003]
HSL S565/S563/S660 +/– Context-dependent phosphorylation [Kraemer and Shen, 2002]
[Watt et al., 2006]
Note: Obvious connections (e.g. transcription, translation, ACORT biosynthesis) are not included in this table.
Table A: Supporting references for cross-talk connections within the adrenal SRN.
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2 Parameter Estimation
The temporal resolution of our experiments is determined by the timescale of the regulatory processes
involved, which was in the order of minutes. We set this as the timescale for our kinetic parameters,
so that all parametric units were expressed in terms of molar concentrations (M) and minutes
(min). Moreover, even though our model equations are considering a single cell system, we must
not forget that our experimental measurements were carried out at the tissue level. This means
our model predictions could be extrapolated to the total number of cells in the adrenal cortex,
provided that the appropriate cellular and nuclear volumes for the di↵erent adrenal cell types are
accounted for. Though we couldn’t find measurements of these volumes in Sprague Dawley rats, we
approximated them from a study of the ultrastructure of Wistar rat adrenal cells, which estimates
the cell and nuclear volume of steroidogenic ZF cells as ⇠ 3600µm3 and ⇠ 260µm3, respectively
[Nickerson, 1976]. Thus, to deal with Molar units in a simpler way, we used the nuclear volume
Vnuc = 2.6⇥ 10 13 lt as it is in this cellular enclosure where gene regulatory reactions take place.
Also, note that the regulatory functions have either sigmoidal or Michaelian shapes and that
they’re normalised (including the multivariate functions). Hence, the overall flux contribution of
these terms is to modulate the weight of kinetic rates (small k’s), whereas their sensitivity to acti-
vation by the independent variable is represented by the half-maximum constants (big K’s), i.e. the
concentration at which the i-th factor reaches ½.
In what follows, we estimate the kinetic rates and other parameter values. A comprehensive
summary of these values is shown in Table B.
2.1 Basal Transcription Rates
The basal transcription rates, denoted by the  ’s, are the rates at which the gene promoters are
activated without the influence of any of the above-mentioned transcription regulators (thought
other factors may be involved), or the minimum level of transcription that these regulators may
exert on the gene (see for instance the influx term in Eq. 7 when ACTH is absent). For the sake of
simplicity, we assumed that basal transcription rates amounted to 5% of the maximum transcription
rates. That is:
 dax1 = 0.05 ⇤ kdax1,  sf1 = 0.05 ⇤ ksf1,  stAR = 0.05 ⇤ kstAR.
2.2 Transcription, Translation and Activation Rates
We calculated the maximum rate of gene expression, assessed by the synthesis of the nascent tran-
script, as:
kgene =
kmaxpol
LhnRNANAVnuc
Dgene (24)
where kgene is the maximum transcription rate of the gene, measured in Molar concentration per
minute; kmaxpol is the maximum elongation speed (processivity rate) of the RNA polymerase, measured
in number of bases synthesised per gene copy per cell per minute and neglecting pauses in polymerase
activity; LhnRNA is the hnRNA transcript length, measured in number of bases per transcript
(including introns); NA is Avogadro’s constant; Vnuc is the nuclear volume of a Zona Fasciculata
(ZF) cell, measured in litres; and Dgene is the gene dosage, or number of gene copies within each
ZF cell.
The maximum processivity rate of the RNA Pol II in mammalian tissue culture cells is estimated
at 71.6nt/sec [Darzacq et al., 2007], corresponding to a maximum elongation speed of kmaxpol ⇡
4.3 kbmin 1. Regarding the gene dosage, we only have information for human Dax1 present as a
duplicate, with both copies active. Thus, we will assume for all genes that Dgene = 2. The only
parameter that remains undetermined in Eq. 24 is the transcript length, which depends on the gene
in question and we calculate below.
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For the Dax1 gene, which in rats is known to encode a hnRNA of 4129 b in length 3, we estimate
a maximum transcription rate of kdax1 = 1.33⇥ 10 11Mmin 1 (after splicing, the mature mRNA
is reduced to 1.8 kb in length 4). Similarly, the SF1 gene in rats is known to encode a hnRNA
of 20825 b in length 5, which we estimate will have a maximum transcription rate of ksf1 = 2.64 ⇥
10 12Mmin 1 (after splicing, the mature mRNA is barely 2182 b in length 6). Lastly, the StAR gene
is known to encode a hnRNA of 4643 b in length 7, for which we estimate a maximum transcription
rate of kstAR = 1.18⇥ 10 11Mmin 1 (after splicing, the predominant transcript variant is a 3.5 kb
mRNA [Ariyoshi et al., 1998]). Thus:
kdax1 = 1.33⇥ 10 11Mmin 1, ksf1 = 2.64⇥ 10 12Mmin 1, kstAR = 1.18⇥ 10 11Mmin 1.
which then implies the basal transcription rates are:
 dax1 = 6.65⇥ 10 13Mmin 1,  sf1 = 1.32⇥ 10 13Mmin 1,  stAR = 5.91⇥ 10 13Mmin 1.
The maturation rates of hnRNA into mRNA are likely subject to high variability given the post-
processing of transcripts depends on multiple, complex reaction steps (e.g. capping, polyadenylation,
splicing, nuclear export) [Keene, 2007]. For the sake of simplicity, we’ll assume their values are half
the above maximum rates of gene expression. Thus, after halving their values and removing Molar
units by multiplying by the product of Avogadro’s constant and the nuclear volume, we arrive to:
kDax1 = 1.04min
 1, kSf1 = 0.21min 1, kStAR = 0.93min 1.
We calculate the translation rate (protein synthesis) for any given transcript in a single ZF cell
as:
kprotein =
krib
Lpoly
(25)
where kprotein is the translation rate of the protein per minute per cell (keeping in mind this rate
should be multiplied by the Molar concentration of mRNAs, so that protein concentration changes
in units of Mmin 1); krib is the polypeptide elongation speed (processivity rate) of the ribosome,
measured in number of codons translated (or aa’s synthesised) per transcript per cell per minute and
assuming ribosome stalling is already accounted for; and Lpoly is the polypeptide length, measured
in number of aa’s (we account for the polypeptide length instead of the mRNA length as UTR
regions do not contribute to protein synthesis). We will use the average ribosome progression rate
for translation in Mus musculus as a proxy for that of rat, which was unavailable. This is estimated
at 5.6± 0.5 codons per second, which equals to krib ⇡ 336 aamin 1 [Ingolia et al., 2011].
Considering the rat DAX1 polypeptide is 472 aa in length 8, we estimate a translation rate of
kDAX1 = 0.71min 1. Similarly, the SF1 polypeptide in rats is 462 aa in length 9, which corresponds
to a translation rate of kSF1 = 0.73min 1. Lastly, for the StAR protein precursor (the 37 kDa form
StARp37), we can assume as a “rule of thumb” a molecular weight of 100-110 Da per average amino
acid [Phillips et al., 2009]; assuming the newly synthesised StARp37 is ⇠ 336 aa in length (the 32
kDa form is 284 aa long 10), we can estimate a translation rate of kStARp37 = 1min 1. Thus:
kDAX1 = 0.71min
 1, kSF1 = 0.73min 1, kStARp37 = 1min 1.
3http://www.ensembl.org/Rattus_norvegicus/Transcript/Exons?db=core;g=ENSRNOG00000003765;r=X:
54734385-54738513;t=ENSRNOT00000005023
4http://www.ncbi.nlm.nih.gov/nuccore/NM_053317.1
5http://www.ensembl.org/Rattus_norvegicus/Transcript/Exons?db=core;g=ENSRNOG00000012682;r=3:
22999616-23020441;t=ENSRNOT00000017651
6http://www.ncbi.nlm.nih.gov/nuccore/NM_001191099.1
7http://www.ensembl.org/Rattus_norvegicus/Transcript/Exons?db=core;g=ENSRNOG00000015052;r=16:
71036204-71040847;t=ENSRNOT00000020606
8http://www.uniprot.org/uniprot/P70503
9http://www.uniprot.org/uniprot/P50569
10http://www.uniprot.org/uniprot/P97826
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Lastly, we chose the parameters kACORT and kGR arbitrarily and allow them to vary during
our model fitting to data as a means to probe the negative feedback strength. For these values, we
assumed
kACORT = 6.39⇥ 10 12Mmin 1, kGR = 1⇥ 10 12Mmin 1.
where the chosen value for kACORT is just 1 divided by the product of the nuclear volume and
Avogadro’s constant.
2.3 Delays
From the HPA model proposed in [Walker et al., 2010], the overall delay for ACTH signal transduc-
tion within the adrenal has been estimated to be ⌧Adrenal 2 [6.5, 20]min. However, recent detailed
experiments suggest two di↵erent time scales for the intra-adrenal network responsiveness, one for
the slow genomic pathway and another for the fast, non-genomic one. Specifically, an intra venous
(i.v.) pulse of ACTH produced rapid, transient increases in plasma CORT, with maximal responses
achieved after 5 to 15 min (though some in vitro studies show ACTH can trigger CORT synthesis
within ⇠ 3min), and a decrease to almost basal levels at ⇠ 30min. In contrast, StAR and P450scc
hnRNA levels increased at 15min following ACTH and decreased towards basal values after 30min
[Spiga et al., 2011a]. Hence, we can assume ⌧Non genomicAdrenal  5min and ⌧GenomicAdrenal ⇡ 15min.
The case of the StAR gene is of particular interest since it is known to control the limiting step
in CORT biosynthesis, which occurs very rapidly during the adrenal response to ACTH stimulation.
From [Miller, 2013], we know that on a 15   60min time scale, ACTH rapidly stimulates both
the activation of pre-existing StAR protein and its de novo the synthesis. ACTH/cAMP doubles
the activity of StAR proteins almost immediately [Arakane et al., 1997] and induces transcription
of the StAR gene within minutes [Manna et al., 2009]. StARp37 then interacts with a complex
macromolecular machine in the Outer Mitochondrial Membrane (OMM) that increases the flow of
cholesterol from the OMM to the Inner Mitochondrial Membrane (IMM), where it becomes the
substrate for CORT biosynthetic enzymes. Thus, we can assume that CORT synthesis is triggered
almost instantaneously, whereas StAR gene expression kicks in until a few minutes later.
We can estimate the delays in the genomic pathway by taking into account the gene and hnRNA
lengths, together with the processivity rate of the RNA Pol II and the ribosome. The StAR gene,
for instance, is known to encode a hnRNA which is 4643 b long. As mentioned before, the maximum
processivity rate of the RNA Pol II in mammalian tissue culture cells is estimated at 71.6nt/sec =
4.3 kb/min [Darzacq et al., 2007], which means the StAR hnRNA would take ⇠ 1.08min to be
transcribed. This transcriptional delay would be unusually short, and we should note that additional
processes occur during transcript elongation, such as cumulative pauses of ⇠ 4min in average for
polymerases on genes. After accounting for stalling e↵ects on a variety of genes, the same study
reports an average processivity rate for RNA Pol II as small as 6.3nt/sec. However, we must
keep in mind that these measurements are subject to high variability, depending on the gene, the
physiological conditions, and the cell type. For instance, in rat kidney cells the reactivation of serum
responsive genes following serum deprivation suggests a synthetic rate of 1.1–1.4 kb/min [Femino
et al., 1998], whereas a more recent study performed on mouse ES cells determined that the RNA
Pol II elongation rates ranged between 0.5 to 4 kb/min [Jonkers et al., 2014]. In summary, several
studies where measurements were taken by di↵erent techniques and in di↵erent conditions place the
RNA Pol II elongation speed between 18 and 72nt/sec [Swinburne and Silver, 2008], with most
studies reporting values in the lower half of this range. Here, we will assume an average value of
30nt/sec = 1.8 kb/min.
Using this average processivity rate, the stAR transcriptional delay would be of 2.58min. Re-
garding transcript editing, we find the duration of an average splicing event has been estimated to
last ⇠ 30 sec [Hnilicova´ and Staneˇk, 2011]. Considering the NCBI reports the StAR gene in Rattus
norvegicus has 6 introns 11, we can estimate it takes ⇠ 3min for stAR hnRNA to mature into StAR
mRNA, assuming introns are removed sequentially instead of simultaneously and neglecting tran-
script export to the translation site. Regarding translation, a ribosome progression rate of 5.6± 0.5
11http://www.ncbi.nlm.nih.gov/gene/25557
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codons per second in Mus musculus has been reported [Ingolia et al., 2011]. Considering a newly
synthesised StARp37 precursor protein would have ⇠ 336 aa in length (the 32 kDa form is 284 aa
long 12), we can estimate a translation delay of ⇠ 1min assuming a “rule of thumb” of 100-110 Da
per average amino acid [Phillips et al., 2009]. Following this, we estimated the delays for StAR gene
expression as
⌧StAR = 5.58min, ⌧StARp37 = 1min.
Likewise, the SF1 gene in rats is known to encode a hnRNA which is 20825 b long. Using the
same average RNA Pol II processivity rate as before, we estimate it would take ⇠ 11.57min to be
transcribed. As the transcript has 6 introns in total 13, we can estimate ⇠ 3min for hnRNA to
mature into mRNA, assuming introns are spliced sequentially and not simultaneously. Regarding
translation, and considering the rat SF1 polypeptide is 462 aa in length 14, we can estimate a
translation delay of ⇠ 1.38min. Following this, we estimated the delays for the SF1 gene expression
as
⌧Sf1 = 14.57min, ⌧SF1 = 1.38min.
Lastly, the Dax1 gene in rats is known to encode a hnRNA which is 4129 b long. Using the
same average RNA Pol II processivity rate as before, we estimate it would take ⇠ 2.29min to
be transcribed. As the transcript has only 1 intron in total 15, we can estimate ⇠ 0.5min for
dax1 hnRNA to mature into Dax1 mRNA. Regarding translation, and considering the rat DAX1
polypeptide is 472 aa in length 16, we can estimate a translation delay of ⇠ 1.4min. Following this,
we estimated the delays for Dax1 gene expression as
⌧Dax1 = 2.79min, ⌧DAX1 = 1.4min.
2.4 Degradation Rates
For simplicity, we’ll assume that immature, uncapped, non-polyadenylated hnRNAs will have a
degradation rate an order of magnitude faster than their mature mRNA counterparts. This results in
half-lives for hnRNAs of ⇠ 20min, comparable to those estimated previously for primary transcripts
in a model of RNA metabolism in mammalian cells [Jackson et al., 2000]. However, after comparing
the model predictions with our data, we required to slightly adjust some of our estimations. This
likely arises from previously unaccounted context-dependent degradation processes, as we will see
in what follows.
Dax1 mRNA half-life is reported by [Ragazzon et al., 2006] to be 3hrs. This value corresponds
to a degradation rate of  Dax1 = 3.85⇥ 10 3min 1. After fitting the model to data regarding the
hnRNA half-life and considering a protein half-life of 6hrs [Osman et al., 2002], we arrive to the
following estimates for the Dax1 gene:
 dax1 = 1.5⇥ 10 2min 1,  Dax1 = 3.85⇥ 10 3min 1,  DAX1 = 1.93⇥ 10 3min 1.
To the best of our knowledge, there is no data available regarding Sf1 mRNA stability. Nonethe-
less, we can assume that, because its mRNA is ⇠ 400 bases longer than the Dax1 transcript, it
degrades at a slower rate. Thus, after calculating a longer half-life in proportion to its length
as compared to the Dax1 transcript, we estimated a degradation rate for the Sf1 mRNA of
3.18⇥10 3min 1. This rate, however, had to be expressed in di↵erent units after the model fitting to
data suggested that this degradation was better represented through a Michaelis-Menten mechanism.
Thus, the Sf1 degradation rate was set to  Sf1 = 2.03⇥10 14Mmin 1. The sf1 hnRNA degrada-
tion rate, in contrast, was assumed an order of magnitude larger than its mRNA counterpart. In the
proper units, this was set as  sf1 = 3.18⇥10 2min 1. Regarding the SF1 protein, previously [Jacob
et al., 2001] and [Chen et al., 2007] have estimated its half-life between 2.5 4hrs, corresponding to
12http://www.uniprot.org/uniprot/P97826
13http://www.ncbi.nlm.nih.gov/gene/83826
14http://www.uniprot.org/uniprot/P50569
15http://www.ncbi.nlm.nih.gov/gene/58850
16http://www.uniprot.org/uniprot/P70503
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a degradation rate within the range 2.89⇥10 3min 1 to 4.62⇥10 3min 1. However, we must take
into account the PKA-mediated stabilisation e↵ects of ACTH upon SF1. For instance, [Æsøy et al.,
2002] found a significant reduction in SF1 protein amount in transfected COS-1 cells in the absence
of PKA-C↵ overexpression measured 4hrs post chase (mean± SEM = 23.7± 4.64%, P = 0.0022),
compared with the amount of SF1 protein after 1hr, which was set to 100%. In contrast, no signifi-
cant reduction in SF1 protein amount was observed after 4hrs in cells cotransfected with PKA-C↵
(mean±SEM = 77.2±9.5%, P = 0.143). Thus, it seems that the turnover of transiently expressed
SF1 was decreased by coexpression of PKA-C↵. Solving the di↵erential equation for first order
degradation, we find the degradation rate is given by:
  =
1
t
ln
x0
x(t)
(26)
which we can use to calculate  PKA SF1 = 8 ⇥ 10 3min 1 and  PKA+SF1 = 1.44 ⇥ 10 3min 1. Here,
we will use the first value, as by including the function g SF1(ACTH) in the turnover term in Eq. 11
we account for the PKA-mediated stabilising e↵ects of ACTH stimuli. Thus, for the SF1 gene, in
the absence of ACTH stimulation, we will have:
 sf1 = 3.18⇥ 10 2min 1,  Sf1 = 2.03⇥ 10 14Mmin 1,  SF1 = 8⇥ 10 3min 1.
The available information regarding StAR mRNA stability is a bit controversial, especially since
two isoforms have been reported, each with di↵erent half-lives and the possibility of selective degra-
dation in steroidogenic cells [Duan and Jefcoate, 2007]. As before, we could make an estimation
based on its transcript length being twice as long as the Dax1 mRNA. Following this, we estimated
a degradation rate of 1.98 ⇥ 10 3min 1. However, at the moment of fitting the model to data
from the ACTH i.v. pulse experiment, we found that this degradation rate had to be approximately
twice as large. Accordingly, we have modified it to  StAR = 3.96 ⇥ 10 3min 1. Likewise, the
value of the stAR hnRNA degradation was adjusted after fitting the model to data and was fixed
at  stAR = 1 ⇥ 10 1min 1. The increase in the  StAR degradation rate, when compared to the
value we originally estimated for StAR mRNA is also supported by experimental evidence showing
this gene contains three conserved AU-rich (AURE) element motifs known to mediate fast mRNA
turnover [Zhao et al., 2005; Duan and Jefcoate, 2007]. Moreover, the measured half-life for the 3.5 kb
StAR mRNA isoform corresponds to a degradation rate of 3.3⇥ 10 3min 1, which is close to our
estimated value.
The estimation of the StARp37 protein turnover rate requires careful examination. According
to [Arakane et al., 1997], the StAR protein has a short half-life, but a specific value is not reported.
The half-life reported by [Ragazzon et al., 2006] is ⇠ 5hrs, with the primary source being [Granot
et al., 2003]. However, this value refers to mitochondrial 30 kDa StAR, which lacks the N-terminus
mitochondrial targeting sequence and it’s not involved in cholesterol import into mitochondria. This
sequence is cleaved upon the StAR 37 kDa import into mitochondria, a process that influences the
rate of the StARp37 precursor cytosolic proteasome degradation, according to [Granot et al., 2003].
Both [Arakane et al., 1998] and [Granot et al., 2003] estimate that the StARp37 precursor has a
half-life of ⇠ 15min. However, this estimate accounts only for proteasome-assisted degradation, and
the authors suggest that a fast import of the precursor into mitochondria would decrease the time it
remains active. This would e↵ectively increase the precursor’s lability when both degradation and
translocation processes are accounted for, thus decreasing the half-life to  5min [Manna et al.,
2009; Clark and Hudson, 2015]. This is consistent with previous estimations of StARp37 exhibiting
a half-life of 5min in mouse Y1 cells [Artemenko et al., 2001], and of 3  4min in rat adrenal cells
incubated at 37 ￿ [Epstein and Orme-Johnson, 1991].
How then is it possible for adrenal cells to exhibit such a fast steroidogenic response while depend-
ing upon a precursor protein that is so labile? As it turns out, PKA-mediated ACTH stimulation
induces rapid phosphorylation of the precursor StARp37, thus stabilising it in the cytosol and en-
hancing its activity. In other words, ACTH stimulation increases the residence time of StARp37 in
the cytosol, thus increasing the rate of cholesterol import into mitochondria and enabling the fast
response of the adrenal to synthesise CORT.
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In summary, we have that when mitochondrial import is blocked, the half-life of the StAR pre-
cursor is 15min, corresponding to  StARp37 = 4.62 ⇥ 10 2min 1; but when both mechanisms are
blocked the precursor accumulates in the cytosol and its half-life increases up to 6.5hrs, correspond-
ing to a much lower turnover rate of µStARp37 =(((( StARp37 +((((✏StARp37 = 1.78⇥ 10 3min 1 [Granot
et al., 2003]. In contrast, when both protein degradation and mitochondrial import are fully func-
tional, and in the absence of ACTH stimulation, the protein is extremely labile, with a half-life of
⇠ 3.5min, corresponding to µACTH StARp37 =  StARp37 + ✏StARp37 = 1.98 ⇥ 10 1min 1 [Epstein and
Orme-Johnson, 1991]. However, upon PKA-mediated phosphorylation of the precursor after ACTH
stimulation, the StARp37 stabilises and its e↵ective turnover rate drops by two orders of magnitude
down to µACTH+StARp37 =  StARp37 + ✏StARp37 = 1.49⇥ 10 3min 1 [Clark and Hudson, 2015]. Thus
µACTH StARp37 = 1.98⇥ 10 1min 1
µACTH+StARp37 = 1.49⇥ 10 3min 1
The transition from a very high to a very low turnover rate for StARp37 is represented in the
second term in Eq. 18 by introducing the function g StARp37(ACTH) (Eq. 19), which modulates
the removal rate µStARp37. As the decrease in the turnover rate upon ACTH stimulation is quite
large, we can fix the parameter as µStARp37 = 1.98 ⇥ 10 1min 1 when no ACTH stimulation is
present and let the function g StARp37(ACTH) stabilise StARp37. Summarising for the StAR gene,
the turnover rates are:
 stAR = 1⇥ 10 1min 1,  StAR = 3.96⇥ 10 3min 1,  StARp37 = 1.98⇥ 10 1min 1.
Though the half-life of intra-adrenal corticosterone (ACORT ) has not been measured directly,
given its rapid export to the bloodstream we can assume it has a faster removal rate than its plasma
counterpart. Assuming a half-life of 1min, we estimate a turnover rate of
µACORT = 6.93⇥ 10 1min 1
Lastly, for the phosphorylated glucocorticoid receptor (pGR), we find from [Bodwell et al., 1998]
that the mouse GR is very stable, with a half-life of ⇠ 18hrs (reduced down to 8   9hrs upon
dexamethasone stimulation). However, we’re interested in the half-life of the active, phosphorylated
form of GR. This is likely to be much more short-lived, but nonetheless has not been measured.
For the sake of simplicity, we assume it’s half-life is the same as that of ACORT , which implies a
turnover rate of
 pGR = 6.93⇥ 10 1min 1
2.5 Half-Maximum Constants
The half-maximum constants (big K’s) are arbitrary parameters that nonetheless capture the sensi-
tivity of a process (e.g. synthesis or degradation) a↵ecting the dynamics of a molecular species Y as
a function of the concentration of another species X. As the molecular mechanisms underlying these
processes are often unknown, we model them as Michaelis-Menten and Hill type functions. In the
latter case, when the Hill coe cient is high enough, these K’s could also be interpreted as activation
thresholds. Though arbitrary, their relative values are informative of how sensitive di↵erent nodes
within the adrenal SRN are to common external stimuli (e.g. ACTH and cytokines).
Half-maximum constants were estimated manually after observing the system’s time evolution
and correcting our model for the timescales at which the peak of the transient response, together
with the rising and decreasing phases, followed the experimental data. The estimated K’s are
listed in Table B and represented graphically in Fig. S9. The half-maximum constants that are
neither dependent on ACTH nor cytokines, but are rather involved in Dax1, Sf1 and StAR mRNA
degradation, in ACORT and pGR synthesis, and in regulation of Dax1 and StAR gene promoters,
were also fixed manually to values close to the range observed during their circadian dynamics.
Of particular interest are the constants KACTH loDax1 and K
ACTH hi
Dax1 which, respectively, represent
the lower and upper near half-maximum constants for a non-monotonous regulatory function (Eq. 5)
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that models dose-dependent e↵ects of ACTH upon Dax1 mRNA stability (Fig. S4). We hypothesise
that this dose-dependent degradation of Dax1 mRNA could be a post-transcriptional regulatory
mechanism such as stress-induced non-sense mediated mRNA decay [He and Jacobson, 2015].
Basal Transcription Rates
 dax1 = 6.65⇥ 10 13Mmin 1  sf1 = 1.32⇥ 10 13Mmin 1  stAR = 5.91⇥ 10 13Mmin 1
Transcription, Translation and Activation Rates
kdax1 = 1.33⇥ 10 11Mmin 1
kDax1 = 1.04min
 1
kDAX1 = 0.71min
 1
kACORT = 6.39⇥ 10 12Mmin 1
ksf1 = 2.64⇥ 10 12Mmin 1
kSf1 = 0.21min
 1
kSF1 = 0.73min
 1
kGR = 1⇥ 10 12Mmin 1
kstAR = 1.18⇥ 10 11Mmin 1
kStAR = 0.93min
 1
kStARp37 = 1min
 1
Degradation Rates
 dax1 = 1.5⇥ 10 2min 1
 Dax1 = 3.85⇥ 10 3min 1
 DAX1 = 1.93⇥ 10 3min 1
µACORT = 6.93⇥ 10 1min 1
 sf1 = 3.18⇥ 10 2min 1
 Sf1 = 2.03⇥ 10 14Mmin 1
 SF1 = 8⇥ 10 3min 1
 pGR = 6.93⇥ 10 1min 1
 stAR = 1⇥ 10 1min 1
 StAR = 3.96⇥ 10 3min 1
µStARp37 = 1.98⇥ 10 1min 1
Delays
⌧Dax1 = 2.79min
⌧DAX1 = 1.4min
⌧Sf1 = 14.57min
⌧SF1 = 1.38min
⌧StAR = 5.58min
⌧StARp37 = 1min
Half-Maximum Constants
KACTHdax1 = 90 pgml
 1
KACTH loDax1 = 30 pgml
 1
KACTH hiDax1 = 1000 pgml
 1
KACTHsf1 = 30 pgml
 1
KACTHSF1 = 70 pgml
 1
KACTHstAR = 70 pgml
 1
KACTHStARp37 = 70 pgml
 1
KACORT = 4.5AU
KG = 0.76AU
KD = 5.7⇥ 10 5M
KSf1 = 1⇥ 10 8M
KSF1 = 6.2⇥ 10 7M
KStAR = 1⇥ 10 8M
KStARp37 = 4⇥ 10 8M
KIL6dax1 = K
IL6
Dax1 = K
IL6
DAX1 = 500AU
KIL6sf1 = 1000AU
KIL6Sf1 = K
IL6
SF1 = 100AU
KIL6StAR = 2500AU
KIL6StARp37 = 500AU
KIL1 stAR = 200AU
KTNF↵stAR = K
TNF↵
StAR = 60AU
KTNF↵pGR = 20AU
Table B: Kinetic rates and other estimated parameter values.
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3 Crosstalk Between the Adrenal SRN and the Immune Path-
way
Stimulation of rats with the bacterial lipopolysaccharide (LPS) endotoxin elicits a strong response
not only at the HPA level but also on the immune system. In particular, LPS induces cytokines
TNF↵, IL1  and IL617, which are known to act upon targets of the adrenal SRN and among
themselves.
A previous mathematical model by [Malek et al., 2015] suggested a way in which LPS, TNF↵
and IL6 may interact with ACTH and CORT to mediate the adrenal response to inflammation.
However, such a model assumed direct interactions of these cytokines upon ACTH, ignoring the
steroidogenic pathway within adrenal cells. LPS e↵ects on the immune system are more complex
and start with the recruitment of macrophages to the adrenal cortex. This increases levels of TNF↵
in a first stage (peak at 60min), and of IL1  and IL6 (in T-lymphocytes) in a second stage (peaks
at 120min) [Givalois et al., 1994]. While it is believed that the first stage is amplified through a
positive feedback, in the second one IL1  and IL6 are known to inhibit rising levels of TNF↵.
Moreover, though CORT is known to inhibit both IL1  and IL6, it has been proposed that IL1 
is involved in the initial activation of CORT production, whereas IL6 sustains it [Givalois et al.,
1994; Kanczkowski et al., 2013]. These interactions between LPS and cytokines, together with the
crosstalk between the immune pathway and the adrenal SRN (Table C), is summarised in Fig. S8.
Even though the interactions among cytokines are complex, we know that the output of the
internal crosstalk within the immune pathway upon an LPS challenge delivers the measured levels
of TNF↵, IL1  and IL6 (Fig. S7a-c). Thus, we can ignore the interactions within the immune
pathway as long as we account for the e↵ects of cytokines upon specific targets of the adrenal SRN.
This e↵ectively means that, during an LPS challenge, in addition to an ACTH input we will now
use the time course of these cytokines as input functions. The task becomes complex as soon as we
realise that the experimental evidence available comes from di↵erent cell types and animal models
(Table C).
3.1 Model Equations for the SRN with Cytokine Interactions
We explored di↵erent network architectures and arrived to the scenario depicted in Fig. 5, which is
associated to the following set of model equations, where the cytokine e↵ects are shown in red:
˙dax1 =  dax1 + kdax1fdax1(SF1, pGR)g
 
dax1(ACTH) dax1(IL6)   dax1dax1,
˙Dax1 = kDax1dax1⌧Dax1 Dax1(IL6)   Dax1Dax1g⌥Dax1(ACTH),
˙DAX1 = kDAX1Dax1⌧DAX1 DAX1(IL6)   DAX1DAX1,
˙sf1 =  sf1 + ksf1g
+
sf1(ACTH) sf1(IL6)   sf1sf1,
˙Sf1 = kSf1sf1⌧Sf1 Sf1(IL6)   Sf1hSf1(Sf1),
˙SF1 = kSF1Sf1⌧SF1 SF1(IL6)   SF1SF1g SF1(ACTH),
˙stAR =  stAR + kstARfstAR(SF1, DAX1)g
+
stAR(ACTH) stAR(TNF↵) stAR(IL1 )   stARstAR,
˙StAR = kStARstAR⌧StAR StAR(TNF↵) StAR(IL6)   StARhStAR(StAR),
˙StARp37 = kStARp37StAR⌧StARp37 StARp37(IL6)  µStARp37StARp37g StARp37(ACTH),
˙ACORT = kACORT fACORT (StARp37)  µACORTACORT,
˙pGR = kGRfpGR(ACORT ) pGR(TNF↵)   pGRpGR.
17The hyphen in TNF-↵, IL-1 , and IL-6 labels was dropped to avoid confusion with a minus sign.
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where
 dax1(IL6) =
KIL6dax1
KIL6dax1 + IL6
,  stAR(TNF↵) = 1 +
TNF↵
KTNF↵stAR + TNF↵
,
 Dax1(IL6) =
KIL6Dax1
KIL6Dax1 + IL6
,  stAR(IL1 ) = 1 +
IL1 
KIL1 stAR + IL1 
,
 DAX1(IL6) =
KIL6DAX1
KIL6DAX1 + IL6
,  StAR(TNF↵) = 1 +
TNF↵
KTNF↵StAR + TNF↵
,
 sf1(IL6) =
KIL6sf1
4
KIL6sf1
4
+ IL64
,  StAR(IL6) =
KIL6StAR
KIL6StAR + IL6
,
 Sf1(IL6) =
KIL6Sf1
4
KIL6Sf1
4
+ IL64
,  StARp37(IL6) =
KIL6StARp37
KIL6StARp37 + IL6
,
 SF1(IL6) =
KIL6SF1
KIL6SF1 + IL6
,  pGR(TNF↵) =
KTNF↵pGR
KTNF↵pGR + TNF↵
.
As before, the half-maximum constants for the cytokine e↵ects upon targets of the adrenal SRN
can be understood as sensitivities. These were estimated by manually fitting the model predictions
to experimental data from the LPS challenge experiments. The values are listed in Table B and
represented graphically in Fig. S9d-f.
Cytokine Target Sign Cell type/species Reference
TNF↵ StAR mRNA/protein – Rat testis Leydig tumor cells (LC-540) [Sadasivam et al., 2015]
StAR mRNA/protein – Mouse macrophage cell line (RAW264.7) [Ma et al., 2007]
DAX1 protein + Rat testis Leydig tumor cells (LC-540) [Sadasivam et al., 2015]
StAR mRNA + Human adrenocortical cells (NCI-H295R) [Tkachenko et al., 2011]
Cortisol – Bovine Zone Fasciculata cells [Barney et al., 2000]
pGR – Human Airway Smooth Muscle cells [Bouazza et al., 2012]
IL1  StAR mRNA + Human adrenocortical cells (NCI-H295R) [Tkachenko et al., 2011]
IL6 StAR mRNA/protein + Bovine Zona Fasciculata cells [McIlmoil et al., 2016]
Dax1 mRNA/protein – Bovine Zona Fasciculata cells [McIlmoil et al., 2016]
SF1 mRNA/protein + Bovine Zona Fasciculata cells [McIlmoil et al., 2016]
StAR mRNA/protein – Bovine Zona Reticularis cells [McIlmoil et al., 2015]
Dax1 mRNA/protein + Bovine Zona Reticularis cells [McIlmoil et al., 2015]
SF1 mRNA/protein – Bovine Zona Reticularis cells [McIlmoil et al., 2015]
StAR mRNA + Human adrenocortical cells (NCI-H295R) [Tkachenko et al., 2011]
Cortisol + Bovine Zona Fasciculata cells [Barney et al., 2000]
LPS StAR 30 kDa – Rat testis Leydig cells [Allen et al., 2004]
[Held Hales et al., 2000]
StAR 30 kDa + Rat adrenal cells [Held Hales et al., 2000]
StAR 37 kDa + Rat testis Leydig tumor cells [Allen et al., 2004]
StAR + Mouse Y1 cells [Calejman et al., 2011]
Corticosterone + Rat adrenal cells [Calejman et al., 2011]
Table C: Cytokine e↵ects upon targets within the adrenal SRN.
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3.2 Scaling Model Outputs of Cytokine Targets
Even though our model predicts the time evolution of hnRNA, mRNA, and protein concentrations,
these predictions are inherently qualitative. This is mainly because we have approximated the
mechanisms underlying gene regulation through Hill type functions and, to a lesser degree, because
our model doesn’t account for regulatory processes a↵ecting mRNA and protein stability.
However, in order to make our model predictions comparable to the experimental data (expressed
in pg/µg for ACORT and as fold induction for all other variables), we have implemented a variable
change to express the model predictions in terms of dimensionless arbitrary units. To do this
consistently, all x state variables in the model were transformed according to the formula:
xˆ =
x  xt=0
xmax   xmin x + o↵set
where xt=0 is the value of x at the time the pulse is given, xmax and xmin are the maximum and
minimum value of the response, and  x is a scaling factor. The o↵set value was set to 1 for all state
variables with data reported as fold induction, except for ACORT, which experiments reported as
pg/µg and for which we set an o↵set of 25, following the baseline observed in ACTH i.v. pulse
experiments.
The scaling factors were adjusted to reproduce the data of the ACTH i.v. pulse experiment, and
these remained invariant when the model was used to predict the high s.c. ACTH pulse and LPS
challenge data without cytokines (Table D). The only scenario where scaling factors were allowed
to vary was after modifying the existing model to account for cytokine e↵ects. Interestingly, in this
latter case most scaling factors remain invariant, except for those multiplying variables targeted by
cytokines. As before, this is because we have used Hill type functions to approximate the mechanisms
by which these pro-inflammatory cytokines interact with targets of the SRN.
Variable
ACTH small ACTH high LPS challenge LPS challenge
i.v. pulse s.c. pulse without cytokines with cytokines
ACORT 300 300 300 300
pGR 3.5 3.5 3.5 0.4
dax1 hnRNA 0.9 0.9 0.9 0.9
Dax1 mRNA 0.4 0.4 0.4 0.8
DAX1 protein 0.1 0.1 0.1 0.6
sf1 hnRNA 0.6 0.6 0.6 0.6
Sf1 mRNA 0.5 0.5 0.5 0.1
SF1 protein 0.2 0.2 0.2 0.2
stAR hnRNA 3 3 3 3
StAR mRNA 2 2 2 2
StARp37 protein 0.1 0.1 0.1 2
Table D: Scaling factors  x. Values in red correspond to non-statistically significant data. All scaling factors
remain invariant in the model, except when the model is modified to account for cytokine inputs (last column)
and only on molecular species targeted by cytokines (Fig. 5).
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